mp:V9.2.0 kwalificatie afhandelenvoorschrift addendum: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Regel 12: | Regel 12: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.1|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind | + | |1.1|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind|| MBH_920_start_eind_TA|| MBH_920_start_eind_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.2a|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur | + | |1.2a|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur|| MBH_920_start_duur_TA|| MBH_920_start_duur_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.2b|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2 | + | |1.2b|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2|| MBH_920_start_duur2_TA|| MBH_920_start_duur2_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.3|| || Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch | + | |1.3|| || Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch|| MBH_920_chronisch_TA|| MBH_920_chronisch_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.4|| Maak screenshot(s) waaruit blijkt dat het extra MVE gemaakt wordt/behoort bij de eerdere TA.|| Extra MVE onder bestaande TA<br/>LET OP: MVE bij de bestaande TA uit scenario 1.3|| MBH_920_chronisch | + | |1.4|| Maak screenshot(s) waaruit blijkt dat het extra MVE gemaakt wordt/behoort bij de eerdere TA.|| Extra MVE onder bestaande TA<br/>LET OP: MVE bij de bestaande TA uit scenario 1.3|| MBH_920_chronisch|| MBH_920_chronisch_TA|| MBH_920_chronisch_MVE_extraMVEbestaandeTA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.5|| || Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks | + | |1.5|| || Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks|| MBH_920_dosis_stuks_TA|| MBH_920_dosis_stuks_MVE |
|} | |} | ||
<section end=overview-AVS-1 /> | <section end=overview-AVS-1 /> | ||
Regel 31: | Regel 31: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.1|| | + | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie (TA)|| MBH_920_aanvullendeinstructie|| MBH_920_aanvullendeinstructie_TA|| MBH_920_aanvullendeinstructie_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.2|| | + | |2.2|| Maak screenshot(s) waaruit blijkt dat bij zowel de TA als MVE een 'toelichting' ingevoerd kan worden|| Toelichting (TA), toelichting (MVE)|| MBH_920_toelichting|| MBH_920_toelichting_TA|| MBH_920_toelichting_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.3|| | + | |2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven (TA)|| MBH_920_redenvanvoorschrijven|| MBH_920_redenvanvoorschrijven_TA|| MBH_920_redenvanvoorschrijven_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.5|| | + | |2.5|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (TA) en 'aanvullende wensen' (MVE) zichtbaar zijn|| Aanvullende informatie (MA), aanvullende wensen (VV)|| MBH_920_aanvullendeinformatiewensen|| MBH_920_aanvullendeinformatiewensen_TA|| MBH_920_aanvullendeinformatiewensen_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.6|| | + | |2.6|| Maak screenshot(s) waarop toedieningsweg keuze zichtbaar is|| Toedieningsweg (TA)|| MBH_920_Toedieningsweg|| MBH_920_Toedieningsweg_TA|| MBH_920_Toedieningsweg_MVE |
|} | |} | ||
<section end=overview-AVS-2 /> | <section end=overview-AVS-2 /> | ||
Regel 48: | Regel 48: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.1|| || | + | |3.1|| || Stop-toedieningsafspraak, met reden staken<br/>LET OP: stop medicatieafspraak van scenario 2.1|| MBH_920_aanvullendeinstructie|| MBH_920_aanvullendeinstructie_TA_staken|| |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.2|| | + | |3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging toedieningsafspraak, met reden wijziging (stop-TA + nieuwe TA) met MVE<br/>LET OP: wijziging toedieningsafspraak van scenario 2.2|| MBH_920_toelichting|| MBH_920_toelichting_TA_wijzigingmetMVE|| MBH_920_toelichting_MVE_extra |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.3|| | + | |3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging toediendingsafspraak, met reden wijziging (stop-TA + nieuwe ma) zonder MVE<br/>LET OP: wijziging toedieningsafspraak van scenario 2.3|| MBH_920_redenvanvoorschrijven|| MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE|| |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.4|| | + | |3.4|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Onderbreken toedieningsafspraak<br/>LET OP: onderbreking toedieningsafspraak van scenario 2.4/2.5|| MBH_920_aanvullendeinformatiewensen|| MBH_920_aanvullendeinformatiewensen_TA_onderbreken|| |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.5|| | + | |3.5|| <div>Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</div>|| <div>Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b</div>|| MBH_920_start_duur2|| MBH_920_start_duur2_TA_techstaken<br>MBH_920_start_duur2_TA_anderePRK|| MBH_920_start_duur2_MVE_anderePRK |
|} | |} | ||
<section end=overview-AVS-3 /> | <section end=overview-AVS-3 /> | ||
Regel 65: | Regel 65: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.1|| || | + | |6.1|| || Variabele frequentie<br/>|| MBH_920_variabelefrequentie|| MBH_920_variabelefrequentie_TA|| MBH_920_variabelefrequentie_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.2|| || | + | |6.2|| || Interval|| MBH_920_interval|| MBH_920_interval_TA|| MBH_920_interval_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.3|| || | + | |6.3|| || Variabele hoeveelheid (1)|| MBH_920_variabelehoeveelheid|| MBH_920_variabelehoeveelheid_TA|| MBH_920_variabelehoeveelheid_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.4|| || | + | |6.4|| || Zonder keerdosis|| MBH_920_zonderkeerdosis|| || MBH_920_zonderkeerdosis_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.5|| || | + | |6.5|| || Bijzondere keerdosis|| MBH_920_bijzonderekeerdosis|| MBH_920_bijzonderekeerdosis_TA|| MBH_920_bijzonderekeerdosis_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.6|| || | + | |6.6|| || Variabele hoeveelheid (2)<br/>|| MBH_920_variabelehoeveelheid2|| MBH_920_variabelehoeveelheid2_TA|| MBH_920_variabelehoeveelheid2_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.7a|| Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden|| Tijdstippen|| MBH_920_tijdstippen_flexibel|| MBH_920_tijdstippen_flexibel_TA|| MBH_920_tijdstippen_flexibel_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.7b|| Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden|| Tijdstippen|| MBH_920_tijdstippen_niet_flexibel|| MBH_920_tijdstippen_niet_flexibel_TA|| MBH_920_tijdstippen_niet_flexibel_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.8|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_920_weekdagen|| MBH_920_weekdagen_TA|| MBH_920_weekdagen_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.9|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_920_dagdeel|| MBH_920_dagdeel_TA|| MBH_920_dagdeel_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.10|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_920_cyclischschema|| MBH_920_cyclischschema_TA|| MBH_920_cyclischschema_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.11|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_920_afbouwschema|| MBH_920_afbouwschema_TA|| MBH_920_afbouwschema_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.12|| || Variabele hoeveelheid en maximum|| MBH_920_variabelehoeveelheidenmaximum|| MBH_920_variabelehoeveelheidenmaximum_TA|| MBH_920_variabelehoeveelheidenmaximum_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.13|| || Toedieningssnelheid|| MBH_920_toedieningssnelheid|| MBH_920_toedieningssnelheid_TA|| MBH_920_toedieningssnelheid_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.15|| | + | |6.14|| || Toedieningsduur|| MBH_920_toedieningsduur|| MBH_920_toedieningsduur_TA|| MBH_920_toedieningsduur_MVE |
+ | |-style="vertical-align:top;|style="background-color: white;" | ||
+ | |6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig<br/>|| MBH_920_zonodig|| MBH_920_zonodig_TA|| MBH_920_zonodig_MVE | ||
|} | |} | ||
<section end=overview-AVS-6 /> | <section end=overview-AVS-6 /> | ||
Regel 102: | Regel 104: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_920_magistraalalleingredienten | + | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_920_magistraalalleingredienten|| MBH_920_magistraalalleingredienten_TA|| MBH_920_magistraalalleingredienten_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_920_magistraalactieveingredient | + | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_920_magistraalactieveingredient|| MBH_920_magistraalactieveingredient_TA|| MBH_920_magistraalactieveingredient_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt <br/>|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr | + | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt <br/>|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr|| MBH_920_magistraal90miljoennr_TA|| MBH_920_magistraal90miljoennr_MVE |
|} | |} | ||
<section end=overview-AVS-7 /> | <section end=overview-AVS-7 /> | ||
Regel 147: | Regel 149: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |10.1|| || HPK geneesmiddel|| MBH_920_HPKvoorschrijven | + | |10.1|| || HPK geneesmiddel|| MBH_920_HPKvoorschrijven|| MBH_920_HPKvoorschrijven_TA|| MBH_920_HPKvoorschrijven_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |10.2|| || ZI-nr geneesmiddel<br/>|| MBH_920_ZINRvoorschrijven | + | |10.2|| || ZI-nr geneesmiddel<br/>|| MBH_920_ZINRvoorschrijven|| MBH_920_ZINRvoorschrijven_TA|| MBH_920_ZINRvoorschrijven_MVE |
|} | |} | ||
<section end=overview-AVS-10 /> | <section end=overview-AVS-10 /> | ||
Regel 160: | Regel 162: | ||
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.1|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind | + | |1.1|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind|| MBH_920_start_eind_TA|| MBH_920_start_eind_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.2a|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur | + | |1.2a|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur|| MBH_920_start_duur_TA|| MBH_920_start_duur_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.2b|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2 | + | |1.2b|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2|| MBH_920_start_duur2_TA|| MBH_920_start_duur2_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.3|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch | + | |1.3|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch|| MBH_920_chronisch_TA|| MBH_920_chronisch_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.4|| Extra MVE onder bestaande TA<br/>LET OP: MVE bij de bestaande TA uit scenario 1.3|| MBH_920_chronisch | + | |1.4|| Extra MVE onder bestaande TA<br/>LET OP: MVE bij de bestaande TA uit scenario 1.3|| MBH_920_chronisch|| MBH_920_chronisch_TA|| MBH_920_chronisch_MVE_extraMVEbestaandeTA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1.5|| Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks | + | |1.5|| Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks|| MBH_920_dosis_stuks_TA|| MBH_920_dosis_stuks_MVE |
|} | |} | ||
<section end=overview-AVO-1 /> | <section end=overview-AVO-1 /> | ||
Regel 179: | Regel 181: | ||
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.1|| | + | |2.1|| Aanvullende instructie (TA)|| MBH_920_aanvullendeinstructie|| MBH_920_aanvullendeinstructie_TA|| MBH_920_aanvullendeinstructie_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.2|| | + | |2.2|| Toelichting (TA), toelichting (MVE)|| MBH_920_toelichting|| MBH_920_toelichting_TA|| MBH_920_toelichting_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.3|| | + | |2.3|| Reden van voorschrijven (TA)|| MBH_920_redenvanvoorschrijven|| MBH_920_redenvanvoorschrijven_TA|| MBH_920_redenvanvoorschrijven_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.5|| | + | |2.5|| Aanvullende informatie (MA), aanvullende wensen (VV)|| MBH_920_aanvullendeinformatiewensen|| MBH_920_aanvullendeinformatiewensen_TA|| MBH_920_aanvullendeinformatiewensen_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |2.6|| | + | |2.6|| Toedieningsweg (TA)|| MBH_920_Toedieningsweg|| MBH_920_Toedieningsweg_TA|| MBH_920_Toedieningsweg_MVE |
|} | |} | ||
<section end=overview-AVO-2 /> | <section end=overview-AVO-2 /> | ||
Regel 196: | Regel 198: | ||
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.1|| | + | |3.1|| Stop-toedieningsafspraak, met reden staken<br/>LET OP: stop medicatieafspraak van scenario 2.1|| MBH_920_aanvullendeinstructie|| MBH_920_aanvullendeinstructie_TA_staken|| |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.2|| | + | |3.2|| Wijziging toedieningsafspraak, met reden wijziging (stop-TA + nieuwe TA) met MVE<br/>LET OP: wijziging toedieningsafspraak van scenario 2.2|| MBH_920_toelichting|| MBH_920_toelichting_TA_wijzigingmetMVE|| MBH_920_toelichting_MVE_extra |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.3|| | + | |3.3|| Wijziging toediendingsafspraak, met reden wijziging (stop-TA + nieuwe ma) zonder MVE<br/>LET OP: wijziging toedieningsafspraak van scenario 2.3|| MBH_920_redenvanvoorschrijven|| MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE|| |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.4|| | + | |3.4|| Onderbreken toedieningsafspraak<br/>LET OP: onderbreking toedieningsafspraak van scenario 2.4/2.5|| MBH_920_aanvullendeinformatiewensen|| MBH_920_aanvullendeinformatiewensen_TA_onderbreken|| |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |3.5|| | + | |3.5|| <div>Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b</div>|| MBH_920_start_duur2|| MBH_920_start_duur2_TA_techstaken<br>MBH_920_start_duur2_TA_anderePRK|| MBH_920_start_duur2_MVE_anderePRK |
|} | |} | ||
<section end=overview-AVO-3 /> | <section end=overview-AVO-3 /> | ||
Regel 213: | Regel 215: | ||
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.1|| | + | |6.1|| Variabele frequentie<br/>|| MBH_920_variabelefrequentie|| MBH_920_variabelefrequentie_TA|| MBH_920_variabelefrequentie_MVE |
+ | |-style="vertical-align:top;|style="background-color: white;" | ||
+ | |6.2|| Interval|| MBH_920_interval|| MBH_920_interval_TA|| MBH_920_interval_MVE | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.3|| Variabele hoeveelheid (1)|| MBH_920_variabelehoeveelheid|| MBH_920_variabelehoeveelheid_TA|| MBH_920_variabelehoeveelheid_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.4|| Zonder keerdosis|| MBH_920_zonderkeerdosis|| || MBH_920_zonderkeerdosis_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.5|| Bijzondere keerdosis|| MBH_920_bijzonderekeerdosis|| MBH_920_bijzonderekeerdosis_TA|| MBH_920_bijzonderekeerdosis_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.6|| Variabele hoeveelheid (2)<br/>|| MBH_920_variabelehoeveelheid2|| MBH_920_variabelehoeveelheid2_TA|| MBH_920_variabelehoeveelheid2_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.7a|| Tijdstippen|| MBH_920_tijdstippen_flexibel|| MBH_920_tijdstippen_flexibel_TA|| MBH_920_tijdstippen_flexibel_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6. | + | |6.7b|| Tijdstippen|| MBH_920_tijdstippen_niet_flexibel|| MBH_920_tijdstippen_niet_flexibel_TA|| MBH_920_tijdstippen_niet_flexibel_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.8|| | + | |6.8|| Weekdagen|| MBH_920_weekdagen|| MBH_920_weekdagen_TA|| MBH_920_weekdagen_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.9|| | + | |6.9|| Dagdeel|| MBH_920_dagdeel|| MBH_920_dagdeel_TA|| MBH_920_dagdeel_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.10|| | + | |6.10|| Cyclisch schema|| MBH_920_cyclischschema|| MBH_920_cyclischschema_TA|| MBH_920_cyclischschema_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.11|| | + | |6.11|| Afbouw schema en doseerduur|| MBH_920_afbouwschema|| MBH_920_afbouwschema_TA|| MBH_920_afbouwschema_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.12|| | + | |6.12|| Variabele hoeveelheid en maximum|| MBH_920_variabelehoeveelheidenmaximum|| MBH_920_variabelehoeveelheidenmaximum_TA|| MBH_920_variabelehoeveelheidenmaximum_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.13|| | + | |6.13|| Toedieningssnelheid|| MBH_920_toedieningssnelheid|| MBH_920_toedieningssnelheid_TA|| MBH_920_toedieningssnelheid_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.14|| | + | |6.14|| Toedieningsduur|| MBH_920_toedieningsduur|| MBH_920_toedieningsduur_TA|| MBH_920_toedieningsduur_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6.15|| | + | |6.15|| Zo nodig<br/>|| MBH_920_zonodig|| MBH_920_zonodig_TA|| MBH_920_zonodig_MVE |
|} | |} | ||
<section end=overview-AVO-6 /> | <section end=overview-AVO-6 /> | ||
Regel 250: | Regel 254: | ||
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |7.1|| Alle ingrediënten|| MBH_920_magistraalalleingredienten | + | |7.1|| Alle ingrediënten|| MBH_920_magistraalalleingredienten|| MBH_920_magistraalalleingredienten_TA|| MBH_920_magistraalalleingredienten_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |7.2|| Actief ingrediënt|| MBH_920_magistraalactieveingredient | + | |7.2|| Actief ingrediënt|| MBH_920_magistraalactieveingredient|| MBH_920_magistraalactieveingredient_TA|| MBH_920_magistraalactieveingredient_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |7.3|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr | + | |7.3|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr|| MBH_920_magistraal90miljoennr_TA|| MBH_920_magistraal90miljoennr_MVE |
|} | |} | ||
<section end=overview-AVO-7 /> | <section end=overview-AVO-7 /> | ||
Regel 295: | Regel 299: | ||
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | | Scenario|| Beschrijving|| MBH id|| TA id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |10.1|| HPK geneesmiddel|| MBH_920_HPKvoorschrijven | + | |10.1|| HPK geneesmiddel|| MBH_920_HPKvoorschrijven|| MBH_920_HPKvoorschrijven_TA|| MBH_920_HPKvoorschrijven_MVE |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |10.2|| ZI-nr geneesmiddel<br/>|| MBH_920_ZINRvoorschrijven | + | |10.2|| ZI-nr geneesmiddel<br/>|| MBH_920_ZINRvoorschrijven|| MBH_920_ZINRvoorschrijven_TA|| MBH_920_ZINRvoorschrijven_MVE |
|} | |} | ||
<section end=overview-AVO-10 /> | <section end=overview-AVO-10 /> | ||
− | == | + | == KWALIFICATIE Scenarioset 1 MA ingangsdatum einddatum== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-1.1-ma_ingangsdatum_einddatum /><section begin=patient-av-mp-ovo-kwa-1.1-ma_ingangsdatum_einddatum /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 314: | Regel 318: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 327: | Regel 331: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-1.1-ma_ingangsdatum_einddatum /><section begin=mbhs-av-mp-ovo-kwa-1.1-ma_ingangsdatum_einddatum /> |
− | ==== Scenario 1.1 - MBH_920_start_eind | + | ==== Scenario 1.1 - MBH_920_start_eind==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_eind_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_eind_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 348: | Regel 352: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_eind_TA | + | |style="background-color: white;"|MBH_920_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 372: | Regel 376: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G- | + | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
Regel 398: | Regel 402: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_start_eind | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_eind_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_eind_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 411: | Regel 415: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_eind_MVE | + | |style="background-color: white;"|MBH_920_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 427: | Regel 431: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G- | + | |style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
Regel 439: | Regel 443: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_start_eind | + | |style="background-color: white;"|MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 458: | Regel 462: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-1.1-ma_ingangsdatum_einddatum /><section end=av-mp-ovo-kwa-1.1-ma_ingangsdatum_einddatum /> |
− | == | + | == KWALIFICATIE Scenarioset 1 MA ingangsdatum en duur (weken)== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-1.2a-ma_ingangsdatum_duur_weken /><section begin=patient-av-mp-ovo-kwa-1.2a-ma_ingangsdatum_duur_weken /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 473: | Regel 477: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 486: | Regel 490: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-1.2a-ma_ingangsdatum_duur_weken /><section begin=mbhs-av-mp-ovo-kwa-1.2a-ma_ingangsdatum_duur_weken /> |
− | ==== Scenario 1.2a - MBH_920_start_duur | + | ==== Scenario 1.2a - MBH_920_start_duur==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_duur_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_duur_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 507: | Regel 511: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur_TA | + | |style="background-color: white;"|MBH_920_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 557: | Regel 561: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_duur_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_duur_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 570: | Regel 574: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur_MVE | + | |style="background-color: white;"|MBH_920_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 598: | Regel 602: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur | + | |style="background-color: white;"|MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 617: | Regel 621: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-1.2a-ma_ingangsdatum_duur_weken /><section end=av-mp-ovo-kwa-1.2a-ma_ingangsdatum_duur_weken /> |
− | == | + | == KWALIFICATIE Scenarioset 1 MA ingangsdatum duur (dagen)== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-1.2b-ma_ingangsdatum_duur_dagen /><section begin=patient-av-mp-ovo-kwa-1.2b-ma_ingangsdatum_duur_dagen /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 632: | Regel 636: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 645: | Regel 649: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-1.2b-ma_ingangsdatum_duur_dagen /><section begin=mbhs-av-mp-ovo-kwa-1.2b-ma_ingangsdatum_duur_dagen /> |
− | ==== Scenario 1.2b - MBH_920_start_duur2 | + | ==== Scenario 1.2b - MBH_920_start_duur2==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_duur2_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_duur2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 666: | Regel 670: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur2_TA | + | |style="background-color: white;"|MBH_920_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 716: | Regel 720: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur2 | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_duur2_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_duur2_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 729: | Regel 733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur2_MVE | + | |style="background-color: white;"|MBH_920_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 757: | Regel 761: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_start_duur2 | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 776: | Regel 780: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-1.2b-ma_ingangsdatum_duur_dagen /><section end=av-mp-ovo-kwa-1.2b-ma_ingangsdatum_duur_dagen /> |
− | == | + | == KWALIFICATIE Scenarioset 1 chronische medicatie== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-1.3-chronische_medicatie /><section begin=patient-av-mp-ovo-kwa-1.3-chronische_medicatie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 791: | Regel 795: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 804: | Regel 808: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-1.3-chronische_medicatie /><section begin=mbhs-av-mp-ovo-kwa-1.3-chronische_medicatie /> |
− | ==== Scenario 1.3 - MBH_920_chronisch | + | ==== Scenario 1.3 - MBH_920_chronisch==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_chronisch_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_chronisch_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 825: | Regel 829: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch_TA | + | |style="background-color: white;"|MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 872: | Regel 876: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_chronisch_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_chronisch_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 885: | Regel 889: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch_MVE | + | |style="background-color: white;"|MBH_920_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 913: | Regel 917: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 932: | Regel 936: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-1.3-chronische_medicatie /><section end=av-mp-ovo-kwa-1.3-chronische_medicatie /> |
− | == | + | == KWALIFICATIE Scenarioset 1 extra VV onder bestaande MA== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-1.4-extra-vv /><section begin=patient-av-mp-ovo-kwa-1.4-extra-vv /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 947: | Regel 951: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 960: | Regel 964: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-1.4-extra-vv /><section begin=mbhs-av-mp-ovo-kwa-1.4-extra-vv /> |
− | ==== Scenario 1.4 - MBH_920_chronisch | + | ==== Scenario 1.4 - MBH_920_chronisch==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_chronisch_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_chronisch_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 981: | Regel 985: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch_TA | + | |style="background-color: white;"|MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 1.028: | Regel 1.032: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_chronisch_MVE_extraMVEbestaandeTA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_chronisch_MVE_extraMVEbestaandeTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.041: | Regel 1.045: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch_MVE_extraMVEbestaandeTA | + | |style="background-color: white;"|MBH_920_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 1.069: | Regel 1.073: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_chronisch | + | |style="background-color: white;"|MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.088: | Regel 1.092: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-1.4-extra-vv /><section end=av-mp-ovo-kwa-1.4-extra-vv /> |
− | == | + | == KWALIFICATIE Scenarioset 1 MA met eeinheid 'dosis/stuks'== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-1.5-eenheid_dosis_stuks /><section begin=patient-av-mp-ovo-kwa-1.5-eenheid_dosis_stuks /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.103: | Regel 1.107: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 1.116: | Regel 1.120: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-1.5-eenheid_dosis_stuks /><section begin=mbhs-av-mp-ovo-kwa-1.5-eenheid_dosis_stuks /> |
− | ==== Scenario 1.5 - MBH_920_dosis_stuks | + | ==== Scenario 1.5 - MBH_920_dosis_stuks==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_dosis_stuks_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_dosis_stuks_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.137: | Regel 1.141: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_dosis_stuks_TA | + | |style="background-color: white;"|MBH_920_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 1.187: | Regel 1.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_dosis_stuks | + | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_dosis_stuks_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_dosis_stuks_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.200: | Regel 1.204: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_dosis_stuks_MVE | + | |style="background-color: white;"|MBH_920_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 1.228: | Regel 1.232: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_dosis_stuks | + | |style="background-color: white;"|MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.247: | Regel 1.251: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-1.5-eenheid_dosis_stuks /><section end=av-mp-ovo-kwa-1.5-eenheid_dosis_stuks /> |
== KWALIFICATIE Scenarioset 2 Aanvullende instructie== | == KWALIFICATIE Scenarioset 2 Aanvullende instructie== | ||
<section begin=av-mp-ovo-kwa-2.1-aanvullendeinstructie /><section begin=patient-av-mp-ovo-kwa-2.1-aanvullendeinstructie /> | <section begin=av-mp-ovo-kwa-2.1-aanvullendeinstructie /><section begin=patient-av-mp-ovo-kwa-2.1-aanvullendeinstructie /> | ||
Regel 1.407: | Regel 1.411: | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|}<section end=mbhs-av-mp-ovo-kwa-2.1-aanvullendeinstructie /><section end=av-mp-ovo-kwa-2.1-aanvullendeinstructie /> | |}<section end=mbhs-av-mp-ovo-kwa-2.1-aanvullendeinstructie /><section end=av-mp-ovo-kwa-2.1-aanvullendeinstructie /> | ||
− | == | + | == KWALIFICATIE Scenarioset 2 Toelichting== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-2.2-toelichting /><section begin=patient-av-mp-ovo-kwa-2.2-toelichting /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.431: | Regel 1.435: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-2.2-toelichting /><section begin=mbhs-av-mp-ovo-kwa-2.2-toelichting /> |
− | ==== Scenario 2. | + | ==== Scenario 2.2 - MBH_920_toelichting==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_toelichting_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.452: | Regel 1.456: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.476: | Regel 1.477: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LASIX TABLET 40MG (code = '220515' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.505: | Regel 1.506: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_toelichting_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.518: | Regel 1.519: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.531: | Regel 1.532: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LASIX TABLET 40MG (code = '220515' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.565: | Regel 1.569: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-2.2-toelichting /><section end=av-mp-ovo-kwa-2.2-toelichting /> |
− | == KWALIFICATIE Scenarioset 2 | + | == KWALIFICATIE Scenarioset 2 Reden van voorschrijven== |
− | <section begin=av-mp-ovo-kwa-2. | + | <section begin=av-mp-ovo-kwa-2.3-redenvanvoorschrijven /><section begin=patient-av-mp-ovo-kwa-2.3-redenvanvoorschrijven /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.600: | Regel 1.604: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-2. | + | |}<section end=patient-av-mp-ovo-kwa-2.3-redenvanvoorschrijven /><section begin=mbhs-av-mp-ovo-kwa-2.3-redenvanvoorschrijven /> |
− | ==== Scenario 2. | + | ==== Scenario 2.3 - MBH_920_redenvanvoorschrijven==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.611: | Regel 1.615: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.632: | Regel 1.639: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.645: | Regel 1.652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.651: | Regel 1.658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 5 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.661: | Regel 1.665: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_redenvanvoorschrijven_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.674: | Regel 1.678: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.687: | Regel 1.691: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|20 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.724: | Regel 1.725: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av-mp-ovo-kwa-2. | + | |}<section end=mbhs-av-mp-ovo-kwa-2.3-redenvanvoorschrijven /><section end=av-mp-ovo-kwa-2.3-redenvanvoorschrijven /> |
− | == | + | == KWALIFICATIE Scenarioset 2 Aanvullende informatie== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-2.5-aanvullendeinformatie /><section begin=patient-av-mp-ovo-kwa-2.5-aanvullendeinformatie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.749: | Regel 1.750: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-2.5-aanvullendeinformatie /><section begin=mbhs-av-mp-ovo-kwa-2.5-aanvullendeinformatie /> |
− | ==== Scenario 2. | + | ==== Scenario 2.5 - MBH_920_aanvullendeinformatiewensen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.770: | Regel 1.771: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.791: | Regel 1.795: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.804: | Regel 1.808: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.810: | Regel 1.814: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.820: | Regel 1.821: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_aanvullendeinformatiewensen_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.833: | Regel 1.834: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.849: | Regel 1.850: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.883: | Regel 1.881: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-2.5-aanvullendeinformatie /><section end=av-mp-ovo-kwa-2.5-aanvullendeinformatie /> |
− | == KWALIFICATIE Scenarioset 2 | + | == KWALIFICATIE Scenarioset 2 Toedieningsweg los== |
− | <section begin=av-mp-ovo-kwa-2. | + | <section begin=av-mp-ovo-kwa-2.6-toedieningsweg_los /><section begin=patient-av-mp-ovo-kwa-2.6-toedieningsweg_los /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.918: | Regel 1.916: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-2. | + | |}<section end=patient-av-mp-ovo-kwa-2.6-toedieningsweg_los /><section begin=mbhs-av-mp-ovo-kwa-2.6-toedieningsweg_los /> |
− | ==== Scenario 2. | + | ==== Scenario 2.6 - MBH_920_Toedieningsweg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_Toedieningsweg_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.929: | Regel 1.927: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.953: | Regel 1.951: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.979: | Regel 1.980: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_Toedieningsweg_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.992: | Regel 1.993: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.005: | Regel 2.006: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 2.039: | Regel 2.040: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av-mp-ovo-kwa-2. | + | |}<section end=mbhs-av-mp-ovo-kwa-2.6-toedieningsweg_los /><section end=av-mp-ovo-kwa-2.6-toedieningsweg_los /> |
− | == | + | == KWALIFICATIE Scenarioset 3 Stop-MA aanvullende instructie met reden van staken== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-3.1-stopma_aanvulendeinstructie /><section begin=patient-av-mp-ovo-kwa-3.1-stopma_aanvulendeinstructie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.064: | Regel 2.065: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-3.1-stopma_aanvulendeinstructie /><section begin=mbhs-av-mp-ovo-kwa-3.1-stopma_aanvulendeinstructie /> |
− | ==== Scenario | + | ==== Scenario 3.1 - MBH_920_aanvullendeinstructie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_aanvullendeinstructie_TA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.085: | Regel 2.086: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.106: | Regel 2.107: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 2.135: | Regel 2.139: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek Jansen en Co |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-3.1-stopma_aanvulendeinstructie /><section end=av-mp-ovo-kwa-3.1-stopma_aanvulendeinstructie /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 3 Wijzigen MA toelichting met reden wijziging== |
− | <section begin=av-mp-ovo-kwa-2 | + | <section begin=av-mp-ovo-kwa-3.2-wijzigma_toelichting /><section begin=patient-av-mp-ovo-kwa-3.2-wijzigma_toelichting /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.230: | Regel 2.196: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-2 | + | |}<section end=patient-av-mp-ovo-kwa-3.2-wijzigma_toelichting /><section begin=mbhs-av-mp-ovo-kwa-3.2-wijzigma_toelichting /> |
− | ==== Scenario 2 | + | ==== Scenario 3.2 - MBH_920_toelichting==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_toelichting_TA_wijzigingmetMVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.241: | Regel 2.207: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_TA_wijzigingmetMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.265: | Regel 2.228: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.278: | Regel 2.241: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.284: | Regel 2.247: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 2.291: | Regel 2.254: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_toelichting_MVE_extra |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.304: | Regel 2.267: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_MVE_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.317: | Regel 2.280: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting_VV_extra |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 2.351: | Regel 2.314: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av-mp-ovo-kwa-2 | + | |}<section end=mbhs-av-mp-ovo-kwa-3.2-wijzigma_toelichting /><section end=av-mp-ovo-kwa-3.2-wijzigma_toelichting /> |
− | == | + | == KWALIFICATIE Scenarioset 3 Wijzigen MA reden van voorschrijven met reden van wijzigen== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-3.3-wijzigma-redenvanvoorschrijven /><section begin=patient-av-mp-ovo-kwa-3.3-wijzigma-redenvanvoorschrijven /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.376: | Regel 2.339: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-3.3-wijzigma-redenvanvoorschrijven /><section begin=mbhs-av-mp-ovo-kwa-3.3-wijzigma-redenvanvoorschrijven /> |
− | ==== Scenario | + | ==== Scenario 3.3 - MBH_920_redenvanvoorschrijven==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.397: | Regel 2.360: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.418: | Regel 2.381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.434: | Regel 2.397: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.440: | Regel 2.403: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 4 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 2.447: | Regel 2.410: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 2.498: | Regel 2.423: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek Jansen en Co |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-3.3-wijzigma-redenvanvoorschrijven /><section end=av-mp-ovo-kwa-3.3-wijzigma-redenvanvoorschrijven /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 3 onderbreken MA toedieningsweg== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-3.4-onderbrekenma_toedieningsweg /><section begin=patient-av-mp-ovo-kwa-3.4-onderbrekenma_toedieningsweg /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.542: | Regel 2.467: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-3.4-onderbrekenma_toedieningsweg /><section begin=mbhs-av-mp-ovo-kwa-3.4-onderbrekenma_toedieningsweg /> |
− | ==== Scenario | + | ==== Scenario 3.4 - MBH_920_aanvullendeinformatiewensen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.553: | Regel 2.478: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 19:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.574: | Regel 2.499: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 2.606: | Regel 2.528: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |rowspan="3"| | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek Jansen en Co |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-3.4-onderbrekenma_toedieningsweg /><section end=av-mp-ovo-kwa-3.4-onderbrekenma_toedieningsweg /> |
− | == | + | == KWALIFICATIE Scenarioset 3 wijziging TA== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-3.5-wijzigingta /><section begin=patient-av-mp-ovo-kwa-3.5-wijzigingta /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.691: | Regel 2.575: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-3.5-wijzigingta /><section begin=mbhs-av-mp-ovo-kwa-3.5-wijzigingta /> |
− | ==== Scenario | + | ==== Scenario 3.5 - MBH_920_start_duur2==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_duur2_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.712: | Regel 2.596: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 51 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 51 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.736: | Regel 2.620: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T - | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 51 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 2.765: | Regel 2.646: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_start_duur2_TA_anderePRK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.778: | Regel 2.659: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 50 dagen om 12:35 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 18 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|18 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 2.790: | Regel 2.682: | ||
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Pantozol niet leverbaar |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Relatie medicatieafspraak | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | + | |} | |
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_start_duur2_MVE_anderePRK |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.871: | Regel 2.722: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2_MVE_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 12:36 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_start_duur2_VV | |
− | |colspan=" | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 2.937: | Regel 2.760: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa-3. | + | |}<section end=mbhs-av-mp-ovo-kwa-3.5-wijzigingta /><section end=av-mp-ovo-kwa-3.5-wijzigingta /> |
− | == | + | == KWALIFICATIE Scenarioset 6 Variabele frequentie== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-6.1-variabele_frequentie /><section begin=patient-av-mp-ovo-kwa-6.1-variabele_frequentie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.961: | Regel 2.784: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 2.971: | Regel 2.794: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.1-variabele_frequentie /><section begin=mbhs-av-mp-ovo-kwa-6.1-variabele_frequentie /> |
− | ==== Scenario | + | ==== Scenario 6.1 - MBH_920_variabelefrequentie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_variabelefrequentie_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.992: | Regel 2.815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.013: | Regel 2.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.045: | Regel 2.865: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_variabelefrequentie_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_variabelefrequentie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | + | |style="background-color: white;"|T om 09:00 uur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background- | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Initialen | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|90 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_variabelefrequentie_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |}<section end=mbhs-av-mp-ovo-kwa-6.1-variabele_frequentie /><section end=av-mp-ovo-kwa-6.1-variabele_frequentie /> | ||
+ | == KWALIFICATIE Scenarioset 6 Interval== | ||
+ | <section begin=av-mp-ovo-kwa-6.2-interval /><section begin=patient-av-mp-ovo-kwa-6.2-interval /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|G. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.092: | Regel 2.950: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-6.2-interval /><section begin=mbhs-av-mp-ovo-kwa-6.2-interval /> |
− | ==== Scenario | + | ==== Scenario 6.2 - MBH_920_interval==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_interval_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.113: | Regel 2.971: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.131: | Regel 2.989: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.147: | Regel 3.005: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, exact iedere 8 uur 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.153: | Regel 3.011: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|exact iedere 8 uur 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.160: | Regel 3.018: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_interval_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.173: | Regel 3.031: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.183: | Regel 3.041: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 3.211: | Regel 3.069: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 3.219: | Regel 3.077: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.2-interval /><section end=av-mp-ovo-kwa-6.2-interval /> |
− | == | + | == KWALIFICATIE Scenarioset 6 Variabele hoeveelheid== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-6.3-variabele_hoeveelheid /><section begin=patient-av-mp-ovo-kwa-6.3-variabele_hoeveelheid /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 3.235: | Regel 3.093: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.245: | Regel 3.103: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.3-variabele_hoeveelheid /><section begin=mbhs-av-mp-ovo-kwa-6.3-variabele_hoeveelheid /> |
− | ==== Scenario 3 | + | ==== Scenario 6.3 - MBH_920_variabelehoeveelheid==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_variabelehoeveelheid_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.266: | Regel 3.124: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - 2 dagen | + | |style="background-color: white;"|T |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.284: | Regel 3.145: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOLUM TABLET 500MG (code = '244716' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.300: | Regel 3.161: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.313: | Regel 3.174: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_variabelehoeveelheid_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.326: | Regel 3.187: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.336: | Regel 3.197: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOLUM TABLET 500MG (code = '244716' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 3.364: | Regel 3.225: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 3.372: | Regel 3.233: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.3-variabele_hoeveelheid /><section end=av-mp-ovo-kwa-6.3-variabele_hoeveelheid /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 6 Zonder keerdosis== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-6.4-zonder_keerdosis /><section begin=patient-av-mp-ovo-kwa-6.4-zonder_keerdosis /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 3.388: | Regel 3.249: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.398: | Regel 3.259: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-6.4-zonder_keerdosis /><section begin=mbhs-av-mp-ovo-kwa-6.4-zonder_keerdosis /> |
− | ==== Scenario | + | ==== Scenario 6.4 - MBH_920_zonderkeerdosis==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_zonderkeerdosis_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.419: | Regel 3.280: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:12 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.440: | Regel 3.290: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_zonderkeerdosis_VV | |
− | |colspan=" | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 3.482: | Regel 3.318: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.4-zonder_keerdosis /><section end=av-mp-ovo-kwa-6.4-zonder_keerdosis /> |
− | == | + | == KWALIFICATIE Scenarioset 6 Bijzondere keerdosis== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-6.5-bijzondere_keerdosis /><section begin=patient-av-mp-ovo-kwa-6.5-bijzondere_keerdosis /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 3.506: | Regel 3.342: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.516: | Regel 3.352: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.5-bijzondere_keerdosis /><section begin=mbhs-av-mp-ovo-kwa-6.5-bijzondere_keerdosis /> |
− | ==== Scenario | + | ==== Scenario 6.5 - MBH_920_bijzonderekeerdosis==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_bijzonderekeerdosis_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.537: | Regel 3.373: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.558: | Regel 3.394: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.574: | Regel 3.410: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.587: | Regel 3.423: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_bijzonderekeerdosis_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | + | |style="background-color: white;"|T om 09:15 uur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background- | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Naamgebruik | + | |colspan="3"|Verstrekte hoeveelheid |
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |}<section end=mbhs-av-mp-ovo-kwa-6.5-bijzondere_keerdosis /><section end=av-mp-ovo-kwa-6.5-bijzondere_keerdosis /> | ||
+ | == KWALIFICATIE Scenarioset 6 Variabele hoeveelheid 2== | ||
+ | <section begin=av-mp-ovo-kwa-6.6-variabele_hoeveelheid_2 /><section begin=patient-av-mp-ovo-kwa-6.6-variabele_hoeveelheid_2 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|G. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 3.634: | Regel 3.508: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-6.6-variabele_hoeveelheid_2 /><section begin=mbhs-av-mp-ovo-kwa-6.6-variabele_hoeveelheid_2 /> |
− | ==== Scenario | + | ==== Scenario 6.6 - MBH_920_variabelehoeveelheid2==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_variabelehoeveelheid2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.655: | Regel 3.529: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.676: | Regel 3.550: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.705: | Regel 3.585: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_variabelehoeveelheid2_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 09:18 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="6"| | + | |rowspan="2"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|450 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |}<section end=mbhs-av-mp-ovo-kwa-6.6-variabele_hoeveelheid_2 /><section end=av-mp-ovo-kwa-6.6-variabele_hoeveelheid_2 /> | ||
+ | == KWALIFICATIE Scenarioset 6 Tijdstippen flexibel== | ||
+ | <section begin=av-mp-ovo-kwa-6.7a-tijdstippen_flexibel /><section begin=patient-av-mp-ovo-kwa-6.7a-tijdstippen_flexibel /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.752: | Regel 3.670: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.7a-tijdstippen_flexibel /><section begin=mbhs-av-mp-ovo-kwa-6.7a-tijdstippen_flexibel /> |
− | ==== Scenario | + | ==== Scenario 6.7a - MBH_920_tijdstippen_flexibel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_tijdstippen_flexibel_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.773: | Regel 3.691: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.794: | Regel 3.712: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.810: | Regel 3.728: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.823: | Regel 3.741: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_tijdstippen_flexibel_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:24 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|42 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_tijdstippen_flexibel_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 3.836: | Regel 3.792: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.7a-tijdstippen_flexibel /><section end=av-mp-ovo-kwa-6.7a-tijdstippen_flexibel /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 6 Tijdstippen niet flexibel== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-6.7b-tijdstippen_niet_flexibel /><section begin=patient-av-mp-ovo-kwa-6.7b-tijdstippen_niet_flexibel /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 3.860: | Regel 3.816: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.870: | Regel 3.826: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-6.7b-tijdstippen_niet_flexibel /><section begin=mbhs-av-mp-ovo-kwa-6.7b-tijdstippen_niet_flexibel /> |
− | ==== Scenario | + | ==== Scenario 6.7b - MBH_920_tijdstippen_niet_flexibel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_tijdstippen_niet_flexibel_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.891: | Regel 3.847: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 10:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.901: | Regel 3.857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.917: | Regel 3.870: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden., oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 3.930: | Regel 3.883: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_tijdstippen_niet_flexibel_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.943: | Regel 3.896: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 10:17 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 3.964: | Regel 3.906: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 4.050: | Regel 3.934: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 4.058: | Regel 3.942: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.7b-tijdstippen_niet_flexibel /><section end=av-mp-ovo-kwa-6.7b-tijdstippen_niet_flexibel /> |
− | == | + | == KWALIFICATIE Scenarioset 6 Weekdagen== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-6.8-weekdagen /><section begin=patient-av-mp-ovo-kwa-6.8-weekdagen /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 4.074: | Regel 3.958: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.084: | Regel 3.968: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.8-weekdagen /><section begin=mbhs-av-mp-ovo-kwa-6.8-weekdagen /> |
− | ==== Scenario | + | ==== Scenario 6.8 - MBH_920_weekdagen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_weekdagen_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.105: | Regel 3.989: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T om 09:25 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 70 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.115: | Regel 4.010: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 4.144: | Regel 4.045: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_weekdagen_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.157: | Regel 4.058: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Verstrekte hoeveelheid | |
− | + | |style="background-color: white;"|30 stuks | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_920_weekdagen_VV | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Zorgaanbieder | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="2"|Organisatie naam | |
− | + | |style="background-color: white;"|Apotheek de Gulle Gaper | |
− | + | |}<section end=mbhs-av-mp-ovo-kwa-6.8-weekdagen /><section end=av-mp-ovo-kwa-6.8-weekdagen /> | |
− | + | == KWALIFICATIE Scenarioset 6 Dagdeel== | |
− | + | <section begin=av-mp-ovo-kwa-6.9-dagdeel /><section begin=patient-av-mp-ovo-kwa-6.9-dagdeel /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | ||
− | |}<section end=mbhs-av- | ||
− | == KWALIFICATIE Scenarioset 6 | ||
− | <section begin=av-mp-ovo-kwa-6. | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 4.288: | Regel 4.120: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.298: | Regel 4.130: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
Regel 4.308: | Regel 4.140: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-6. | + | |}<section end=patient-av-mp-ovo-kwa-6.9-dagdeel /><section begin=mbhs-av-mp-ovo-kwa-6.9-dagdeel /> |
− | ==== Scenario 6. | + | ==== Scenario 6.9 - MBH_920_dagdeel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_dagdeel_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.319: | Regel 4.151: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:27 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.343: | Regel 4.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.356: | Regel 4.185: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 4.369: | Regel 4.198: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_dagdeel_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 09:27 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|60 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_dagdeel_VV | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 4.391: | Regel 4.258: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
− | |}<section end=mbhs-av-mp-ovo-kwa-6. | + | |}<section end=mbhs-av-mp-ovo-kwa-6.9-dagdeel /><section end=av-mp-ovo-kwa-6.9-dagdeel /> |
− | == | + | == KWALIFICATIE Scenarioset 6 Cyclisch schema== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-6.10-cyclisch_schema /><section begin=patient-av-mp-ovo-kwa-6.10-cyclisch_schema /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 4.406: | Regel 4.273: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.416: | Regel 4.283: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.10-cyclisch_schema /><section begin=mbhs-av-mp-ovo-kwa-6.10-cyclisch_schema /> |
− | ==== Scenario 6. | + | ==== Scenario 6.10 - MBH_920_cyclischschema==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_cyclischschema_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.437: | Regel 4.304: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:33 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.461: | Regel 4.325: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|maal per dag 1 stuk | + | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 4.487: | Regel 4.351: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_cyclischschema_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.500: | Regel 4.364: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_cyclischschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:33 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.513: | Regel 4.377: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|126 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_cyclischschema_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 4.547: | Regel 4.411: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.10-cyclisch_schema /><section end=av-mp-ovo-kwa-6.10-cyclisch_schema /> |
− | == KWALIFICATIE Scenarioset 6 | + | == KWALIFICATIE Scenarioset 6 Afbouwschema== |
− | <section begin=av-mp-ovo-kwa-6. | + | <section begin=av-mp-ovo-kwa-6.11-afbouwschema /><section begin=patient-av-mp-ovo-kwa-6.11-afbouwschema /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 4.562: | Regel 4.426: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.572: | Regel 4.436: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
Regel 4.582: | Regel 4.446: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-6. | + | |}<section end=patient-av-mp-ovo-kwa-6.11-afbouwschema /><section begin=mbhs-av-mp-ovo-kwa-6.11-afbouwschema /> |
− | ==== Scenario 6. | + | ==== Scenario 6.11 - MBH_920_afbouwschema==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_afbouwschema_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.593: | Regel 4.457: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:40 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.614: | Regel 4.481: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie 1 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 3 | ||
+ | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 4.640: | Regel 4.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_afbouwschema_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.653: | Regel 4.526: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afbouwschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:40 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.666: | Regel 4.539: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"|90 | + | |style="background-color: white;"|90 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afbouwschema_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 4.700: | Regel 4.573: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
− | |}<section end=mbhs-av-mp-ovo-kwa-6. | + | |}<section end=mbhs-av-mp-ovo-kwa-6.11-afbouwschema /><section end=av-mp-ovo-kwa-6.11-afbouwschema /> |
− | == | + | == KWALIFICATIE Scenarioset 6 Variabele hoeveelheid en maximum== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-6.12-variabele_hoeveelheid_en_maximum /><section begin=patient-av-mp-ovo-kwa-6.12-variabele_hoeveelheid_en_maximum /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 4.715: | Regel 4.588: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.725: | Regel 4.598: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.12-variabele_hoeveelheid_en_maximum /><section begin=mbhs-av-mp-ovo-kwa-6.12-variabele_hoeveelheid_en_maximum /> |
− | ==== Scenario 6. | + | ==== Scenario 6.12 - MBH_920_variabelehoeveelheidenmaximum==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_variabelehoeveelheidenmaximum_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.746: | Regel 4.619: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 21 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.767: | Regel 4.643: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.780: | Regel 4.656: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest stuks , maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest stuks , maximaal 6 stuks per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 4.793: | Regel 4.669: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_variabelehoeveelheidenmaximum_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.806: | Regel 4.682: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.819: | Regel 4.695: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|120 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 4.853: | Regel 4.729: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.12-variabele_hoeveelheid_en_maximum /><section end=av-mp-ovo-kwa-6.12-variabele_hoeveelheid_en_maximum /> |
− | == KWALIFICATIE Scenarioset 6 | + | == KWALIFICATIE Scenarioset 6 Toedieningssnelheid== |
− | <section begin=av-mp-ovo-kwa-6. | + | <section begin=av-mp-ovo-kwa-6.13-toedieningssnelheid /><section begin=patient-av-mp-ovo-kwa-6.13-toedieningssnelheid /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 4.868: | Regel 4.744: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.878: | Regel 4.754: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
Regel 4.888: | Regel 4.764: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-6. | + | |}<section end=patient-av-mp-ovo-kwa-6.13-toedieningssnelheid /><section begin=mbhs-av-mp-ovo-kwa-6.13-toedieningssnelheid /> |
− | ==== Scenario 6. | + | ==== Scenario 6.13 - MBH_920_toedieningssnelheid==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_toedieningssnelheid_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.899: | Regel 4.775: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:47 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 4.913: | Regel 4.789: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 8 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 4.923: | Regel 4.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.936: | Regel 4.812: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: ml per uur, parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|toedieningssnelheid: ml per uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 4.949: | Regel 4.825: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_toedieningssnelheid_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | + | |style="background-color: white;"|T om 09:47 uur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background- | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="6"| | + | |rowspan="2"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |}<section end=mbhs-av-mp-ovo-kwa-6.13-toedieningssnelheid /><section end=av-mp-ovo-kwa-6.13-toedieningssnelheid /> | ||
+ | == KWALIFICATIE Scenarioset 6 Toedieningsduur== | ||
+ | <section begin=av-mp-ovo-kwa-6.14-toedieningsduur /><section begin=patient-av-mp-ovo-kwa-6.14-toedieningsduur /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 4.996: | Regel 4.910: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-6.14-toedieningsduur /><section begin=mbhs-av-mp-ovo-kwa-6.14-toedieningsduur /> |
− | ==== Scenario 6. | + | ==== Scenario 6.14 - MBH_920_toedieningsduur==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_toedieningsduur_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.017: | Regel 4.931: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:49 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 5.041: | Regel 4.952: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.054: | Regel 4.965: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 5.067: | Regel 4.978: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_toedieningsduur_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.080: | Regel 4.991: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningsduur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:49 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 5.093: | Regel 5.004: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningsduur_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 5.127: | Regel 5.038: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.14-toedieningsduur /><section end=av-mp-ovo-kwa-6.14-toedieningsduur /> |
− | == KWALIFICATIE Scenarioset 6 | + | == MP KWALIFICATIE Scenarioset 6 Zo nodig== |
− | <section begin=av-mp-ovo-kwa-6. | + | <section begin=av-mp-ovo-kwa-6.15-zonodig /><section begin=patient-av-mp-ovo-kwa-6.15-zonodig /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 5.142: | Regel 5.053: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 5.152: | Regel 5.063: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
Regel 5.162: | Regel 5.073: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa-6. | + | |}<section end=patient-av-mp-ovo-kwa-6.15-zonodig /><section begin=mbhs-av-mp-ovo-kwa-6.15-zonodig /> |
− | == | + | ==== Scenario 6.15 - MBH_920_zonodig==== |
− | + | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_zonodig_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 09:57 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="2"|Ingangsdatum | |
− | + | |style="background-color: white;"|T | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 27 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 5.232: | Regel 5.108: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 5.261: | Regel 5.134: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_zonodig_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.274: | Regel 5.147: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonodig_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T om 09:57 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 5.287: | Regel 5.160: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|14 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonodig_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 5.321: | Regel 5.194: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek de Gulle Gaper | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-6.15-zonodig /><section end=av-mp-ovo-kwa-6.15-zonodig /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 7 alle ingrediënten== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-7.1-alle_ingredienten /><section begin=patient-av-mp-ovo-kwa-7.1-alle_ingredienten /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 5.336: | Regel 5.209: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 5.346: | Regel 5.219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hess |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900614 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-7.1-alle_ingredienten /><section begin=mbhs-av-mp-ovo-kwa-7.1-alle_ingredienten /> |
− | ==== Scenario | + | ==== Scenario 7.1 - MBH_920_magistraalalleingredienten==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_magistraalalleingredienten_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 31 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="11"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |rowspan="3"| |
− | |style="background-color: white;"|2 | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Ingredient code | ||
+ | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="5"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_magistraalalleingredienten_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Identificatie |
+ | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 13:00 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="11"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Ingredient |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalalleingredienten_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | | | + | |} |
− | + | ==== Bouwstenen ==== | |
− | | | + | {| class="wikitable" width="85%" |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | |
− | | | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | + | |colspan="3" width="25%"| Gegevenselement | |
− | + | || Waarde | |
− | + | ||
− | |||
− | |style="background-color: white; | ||
− | |||
− | |colspan=" | ||
− | | | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | + | |}<section end=mbhs-av-mp-ovo-kwa-7.1-alle_ingredienten /><section end=av-mp-ovo-kwa-7.1-alle_ingredienten /> | |
+ | == KWALIFICATIE Scenarioset 7 Actief ingrediënt== | ||
+ | <section begin=av-mp-ovo-kwa-7.2-actief_ingredient /><section begin=patient-av-mp-ovo-kwa-7.2-actief_ingredient /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hess |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900614 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
+ | |}<section end=patient-av-mp-ovo-kwa-7.2-actief_ingredient /><section begin=mbhs-av-mp-ovo-kwa-7.2-actief_ingredient /> | ||
+ | ==== Scenario 7.2 - MBH_920_magistraalactieveingredient==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_magistraalactieveingredient_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 13:05 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 70 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_magistraalactieveingredient_MVE | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 13:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 gram |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Sterkte |
+ | |style="background-color: white;"| per | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalactieveingredient_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 5.710: | Regel 5.561: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 5.718: | Regel 5.569: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-7.2-actief_ingredient /><section end=av-mp-ovo-kwa-7.2-actief_ingredient /> |
− | == | + | == KWALIFICATIE Scenarioset 7 90 miljoennummer== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-7.3-90_miljoen_nr /><section begin=patient-av-mp-ovo-kwa-7.3-90_miljoen_nr /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 5.734: | Regel 5.585: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 5.744: | Regel 5.595: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hess |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900614 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-7.3-90_miljoen_nr /><section begin=mbhs-av-mp-ovo-kwa-7.3-90_miljoen_nr /> |
− | ==== Scenario | + | ==== Scenario 7.3 - MBH_920_magistraal90miljoennr==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_920_magistraal90miljoennr_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 13:08 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_920_magistraal90miljoennr_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 13:08 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 gram |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="8"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Zorgaanbieder identificatienummer | + | |colspan="2"|Ingredient code |
+ | |style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr_VV | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-7.3-90_miljoen_nr /><section end=av-mp-ovo-kwa-7.3-90_miljoen_nr /> |
− | == | + | == KWALIFICATIE Scenarioset 8 VV onder andermans MA== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-8.1-vv_onder_andermans_ma /><section begin=patient-av-mp-ovo-kwa-8.1-vv_onder_andermans_ma /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 5.893: | Regel 5.766: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 5.903: | Regel 5.776: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="2"| | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-8.1-vv_onder_andermans_ma /><section begin=mbhs-av-mp-ovo-kwa-8.1-vv_onder_andermans_ma /> |
− | ==== Scenario | + | ==== Scenario 8.1 - MBH_920_VVandermansMA-ZTP==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_MVEandermansTA_TA-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.927: | Regel 5.803: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_MVEandermansTA_TA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 14 dagen om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 5.948: | Regel 5.824: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.964: | Regel 5.840: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 5.977: | Regel 5.853: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_MVEandermansTA_MVE-ZTP | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_MVEandermansTA_MVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 10:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|6 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_VVandermansMA_VV-ZTP | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_VVandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 5.990: | Regel 5.904: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 5.998: | Regel 5.912: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-8.1-vv_onder_andermans_ma /><section end=av-mp-ovo-kwa-8.1-vv_onder_andermans_ma /> |
− | == | + | == KWALIFICATIE Scenarioset 8 Staken andermans MA== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-8.2-staken_andermans_ma /><section begin=patient-av-mp-ovo-kwa-8.2-staken_andermans_ma /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 6.011: | Regel 5.925: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 6.021: | Regel 5.935: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="2"| | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-8.2-staken_andermans_ma /><section begin=mbhs-av-mp-ovo-kwa-8.2-staken_andermans_ma /> |
− | ==== Scenario | + | ==== Scenario 8.2 - MBH_920_stakenandermansMA-ZTP==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_stakenandermansTA_TA2-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.045: | Regel 5.962: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_stakenandermansTA_TA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 10:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.066: | Regel 5.983: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ZESTRIL TABLET 10MG (code = '615560' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 6.082: | Regel 5.999: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 6.095: | Regel 6.012: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_stakenandermansMA_MA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_stakenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_stakenandermansTA_andermansMVE-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.108: | Regel 6.025: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_stakenandermansTA_andermansMVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om 09: | + | |style="background-color: white;"|T - 5 dagen om 09:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.118: | Regel 6.035: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ZESTRIL TABLET 10MG (code = '615560' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_stakenandermansMA_andermansVV-ZTP |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_stakenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 6.146: | Regel 6.063: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 6.154: | Regel 6.071: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-8.2-staken_andermans_ma /><section end=av-mp-ovo-kwa-8.2-staken_andermans_ma /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 8 Onderbreken andermans MA== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-8.3-onderbreken_andermans_ma /><section begin=patient-av-mp-ovo-kwa-8.3-onderbreken_andermans_ma /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 6.167: | Regel 6.084: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 6.177: | Regel 6.094: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="2"| | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-8.3-onderbreken_andermans_ma /><section begin=mbhs-av-mp-ovo-kwa-8.3-onderbreken_andermans_ma /> |
− | ==== Scenario | + | ==== Scenario 8.3 - MBH_920_onderbrekenandermansMA-ZTP==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_onderbrekenandermansTA_TA2-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.201: | Regel 6.121: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbrekenandermansTA_TA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 10:07 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.222: | Regel 6.142: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 6.257: | Regel 6.171: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_onderbrekenandermansTA_andermansMVE-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_onderbrekenandermansTA_andermansMVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 60 dagen om 10:00 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_andermansVV-ZTP |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
+ | |}<section end=mbhs-av-mp-ovo-kwa-8.3-onderbreken_andermans_ma /><section end=av-mp-ovo-kwa-8.3-onderbreken_andermans_ma /> | ||
+ | == KWALIFICATIE Scenarioset 8 Wijzigen andermans MA== | ||
+ | <section begin=av-mp-ovo-kwa-8.4-wijzigen_andermans_ma /><section begin=patient-av-mp-ovo-kwa-8.4-wijzigen_andermans_ma /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Voorvoegsels |
− | |style="background-color: white;"| | + | |style="background-color: white;"|van |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Achternaam |
+ | |style="background-color: white;"|XXX_Meijs | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | | | + | |}<section end=patient-av-mp-ovo-kwa-8.4-wijzigen_andermans_ma /><section begin=mbhs-av-mp-ovo-kwa-8.4-wijzigen_andermans_ma /> |
− | + | ==== Scenario 8.4 - MBH_920_wijzigenandermansMA-ZTP==== | |
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_wijzigenandermansTA_TA_techstaken-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.394: | Regel 6.280: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wijzigenandermansTA_TA_techstaken-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 10:10 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 7 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T - 1 dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.404: | Regel 6.301: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA_techstaken-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_wijzigenandermansTA_andermansMVE-ZTP |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_wijzigenandermansTA_andermansMVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 7 dagen om 08:50 uur |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|42 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wijzigenandermansMA_andermansVV-ZTP |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
+ | |}<section end=mbhs-av-mp-ovo-kwa-8.4-wijzigen_andermans_ma /><section end=av-mp-ovo-kwa-8.4-wijzigen_andermans_ma /> | ||
+ | == KWALIFICATIE Scenarioset 9 Verbruiksperiode (start/eind)== | ||
+ | <section begin=av-mp-ovo-kwa-9.1a-verbruiksperiode_start_eind /><section begin=patient-av-mp-ovo-kwa-9.1a-verbruiksperiode_start_eind /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Naamgegevens |
− | |style="background-color: #E3E3E3;;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Initialen |
+ | |style="background-color: white;"|M. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Zorgaanbieder | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|XXX_Nederveen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900833 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|28 okt 1985 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=patient-av-mp-ovo-kwa-9.1a-verbruiksperiode_start_eind /><section begin=mbhs-av-mp-ovo-kwa-9.1a-verbruiksperiode_start_eind /> | ||
+ | ==== Scenario 9.1a - MBH_920_logistiekeverbruiksperiode_start_eind-BSC==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_start_eind_TA-BSC | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen, tot en met T + 12 maanden'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T + 10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 12 maanden | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 6.521: | Regel 6.473: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, 1 stuk | + | |style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 6.534: | Regel 6.486: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_start_eind_MVE-BSC |
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 12:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_VV-BSC | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.547: | Regel 6.537: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 6.555: | Regel 6.545: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-9.1a-verbruiksperiode_start_eind /><section end=av-mp-ovo-kwa-9.1a-verbruiksperiode_start_eind /> |
− | == | + | == KWALIFICATIE Scenarioset 9 Verbruiksperiode einddatum== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-9.1b-verbruiksperiode_einddatum /><section begin=patient-av-mp-ovo-kwa-9.1b-verbruiksperiode_einddatum /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 6.571: | Regel 6.561: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 6.581: | Regel 6.571: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Nederveen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900833 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-9.1b-verbruiksperiode_einddatum /><section begin=mbhs-av-mp-ovo-kwa-9.1b-verbruiksperiode_einddatum /> |
− | ==== Scenario | + | ==== Scenario 9.1b - MBH_920_logistiekeverbruiksperiode_eind-BSC==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_eind_TA-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.602: | Regel 6.592: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 9 dagen om 12:01 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 200 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 9 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 200 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.620: | Regel 6.613: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 6.636: | Regel 6.629: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, 1 stuk | + | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 6.649: | Regel 6.642: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_eind_MVE-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.662: | Regel 6.655: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 9 dagen om 12:01 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.672: | Regel 6.665: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_VV-BSC |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 6.700: | Regel 6.693: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 6.708: | Regel 6.701: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-9.1b-verbruiksperiode_einddatum /><section end=av-mp-ovo-kwa-9.1b-verbruiksperiode_einddatum /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 9 verbruiksperiode duur (dagen)== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-9.1c-verbruiksperiode_duur /><section begin=patient-av-mp-ovo-kwa-9.1c-verbruiksperiode_duur /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 6.724: | Regel 6.717: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 6.734: | Regel 6.727: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Nederveen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900833 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-9.1c-verbruiksperiode_duur /><section begin=mbhs-av-mp-ovo-kwa-9.1c-verbruiksperiode_duur /> |
− | ==== Scenario | + | ==== Scenario 9.1c - MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_TA-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.755: | Regel 6.748: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 150 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.773: | Regel 6.769: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 6.802: | Regel 6.798: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE-BSC | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieverstrekkings datum tijd | ||
+ | |style="background-color: white;"|T om 12:02 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verbruiksduur | ||
+ | |style="background-color: white;"|50 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_VV-BSC | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 6.815: | Regel 6.852: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 6.823: | Regel 6.860: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av-mp-ovo-kwa- | + | |}<section end=mbhs-av-mp-ovo-kwa-9.1c-verbruiksperiode_duur /><section end=av-mp-ovo-kwa-9.1c-verbruiksperiode_duur /> |
− | == | + | == KWALIFICATIE Scenarioset 9 Herhalingen== |
− | <section begin=av- | + | <section begin=av-mp-ovo-kwa-9.2-herhalingen /><section begin=patient-av-mp-ovo-kwa-9.2-herhalingen /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 6.839: | Regel 6.876: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 6.849: | Regel 6.886: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Nederveen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900833 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-9.2-herhalingen /><section begin=mbhs-av-mp-ovo-kwa-9.2-herhalingen /> |
− | ==== Scenario | + | ==== Scenario 9.2 - MBH_920_herhalingen-BSC==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_herhalingen_TA-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.870: | Regel 6.907: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_herhalingen_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 50 dagen om 12:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 50 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.888: | Regel 6.925: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 6.917: | Regel 6.954: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_herhalingen_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_herhalingen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_herhalingen_MVE-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 6.930: | Regel 6.967: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_herhalingen_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 50 dagen om 12:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 6.940: | Regel 6.977: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_herhalingen_VV-BSC |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_herhalingen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 6.968: | Regel 7.005: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 6.976: | Regel 7.013: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-9.2-herhalingen /><section end=av-mp-ovo-kwa-9.2-herhalingen /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 9 Afleverlocatie== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-9.3-afleverlocatie /><section begin=patient-av-mp-ovo-kwa-9.3-afleverlocatie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 6.992: | Regel 7.029: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 7.002: | Regel 7.039: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Nederveen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900833 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av-mp-ovo-kwa- | + | |}<section end=patient-av-mp-ovo-kwa-9.3-afleverlocatie /><section begin=mbhs-av-mp-ovo-kwa-9.3-afleverlocatie /> |
− | ==== Scenario | + | ==== Scenario 9.3 - MBH_920_afleverlocatie-BSC==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_afleverlocatie_TA-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 7.023: | Regel 7.060: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afleverlocatie_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:07 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 7.044: | Regel 7.081: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie |
− | + | |style="background-color: white;"|3 maal per dag 1 stuk | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 7.079: | Regel 7.110: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afleverlocatie_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_afleverlocatie-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_afleverlocatie_MVE-BSC |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_920_afleverlocatie_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieverstrekkings datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 12:07 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Initialen | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afleverlocatie | ||
+ | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie_VV-BSC | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_920_afleverlocatie-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |}<section end=mbhs-av-mp-ovo-kwa-9.3-afleverlocatie /><section end=av-mp-ovo-kwa-9.3-afleverlocatie /> | ||
+ | == KWALIFICATIE Scenarioset 10 HPK geneesmiddel== | ||
+ | <section begin=av-mp-ovo-kwa-10.1-hpk_geneesmiddel /><section begin=patient-av-mp-ovo-kwa-10.1-hpk_geneesmiddel /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|M. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 7.126: | Regel 7.198: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Niesing |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900845 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|29 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-10.1-hpk_geneesmiddel /><section begin=mbhs-av-mp-ovo-kwa-10.1-hpk_geneesmiddel /> |
− | ==== Scenario | + | ==== Scenario 10.1 - MBH_920_HPKvoorschrijven==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_HPKvoorschrijven_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 7.147: | Regel 7.219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 170 dagen om 14:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 170 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 7.168: | Regel 7.240: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie |
− | + | |style="background-color: white;"|1 maal per dag 1 stuk | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 7.203: | Regel 7.269: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_HPKvoorschrijven_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 7.216: | Regel 7.282: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 170 dagen om 14:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 7.226: | Regel 7.292: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekte hoeveelheid | |colspan="3"|Verstrekte hoeveelheid | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|150 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie verstrekkingsverzoek | |colspan="3"|Relatie verstrekkingsverzoek | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven_VV |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 7.254: | Regel 7.320: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
Regel 7.262: | Regel 7.328: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-10.1-hpk_geneesmiddel /><section end=av-mp-ovo-kwa-10.1-hpk_geneesmiddel /> |
− | == KWALIFICATIE Scenarioset | + | == KWALIFICATIE Scenarioset 10 ZI-nummer geneesmiddel== |
− | <section begin=av-mp-ovo-kwa- | + | <section begin=av-mp-ovo-kwa-10.2-zi_nummer_geneesmiddel /><section begin=patient-av-mp-ovo-kwa-10.2-zi_nummer_geneesmiddel /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 7.278: | Regel 7.344: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 7.288: | Regel 7.354: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Niesing |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900845 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|29 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient-av- | + | |}<section end=patient-av-mp-ovo-kwa-10.2-zi_nummer_geneesmiddel /><section begin=mbhs-av-mp-ovo-kwa-10.2-zi_nummer_geneesmiddel /> |
− | ==== Scenario 10.2 - MBH_920_ZINRvoorschrijven | + | ==== Scenario 10.2 - MBH_920_ZINRvoorschrijven==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_ZINRvoorschrijven_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_920_ZINRvoorschrijven_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 10.555: | Regel 7.375: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_TA | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak datum tijd | |colspan="3"|Toedieningsafspraak datum tijd | ||
Regel 10.608: | Regel 7.428: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77. | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_ZINRvoorschrijven_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_920_ZINRvoorschrijven_MVE |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 10.621: | Regel 7.441: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MVE | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Medicatieverstrekkings datum tijd | |colspan="3"|Medicatieverstrekkings datum tijd | ||
Regel 10.652: | Regel 7.472: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven | + | |style="background-color: white;"|MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 10.671: | Regel 7.491: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-av- | + | |}<section end=mbhs-av-mp-ovo-kwa-10.2-zi_nummer_geneesmiddel /><section end=av-mp-ovo-kwa-10.2-zi_nummer_geneesmiddel /> |
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] |
Versie van 27 aug 2021 07:04
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset 1
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
1.1 | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum). | Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum | MBH_920_start_eind | MBH_920_start_eind_TA | MBH_920_start_eind_MVE |
1.2a | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken) | MBH_920_start_duur | MBH_920_start_duur_TA | MBH_920_start_duur_MVE |
1.2b | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen) | MBH_920_start_duur2 | MBH_920_start_duur2_TA | MBH_920_start_duur2_MVE |
1.3 | Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie) | MBH_920_chronisch | MBH_920_chronisch_TA | MBH_920_chronisch_MVE | |
1.4 | Maak screenshot(s) waaruit blijkt dat het extra MVE gemaakt wordt/behoort bij de eerdere TA. | Extra MVE onder bestaande TA LET OP: MVE bij de bestaande TA uit scenario 1.3 |
MBH_920_chronisch | MBH_920_chronisch_TA | MBH_920_chronisch_MVE_extraMVEbestaandeTA |
1.5 | Afhandeling medicatievoorschrift met eenheid 'dosis/stuks' | MBH_920_dosis_stuks | MBH_920_dosis_stuks_TA | MBH_920_dosis_stuks_MVE |
1.1.2 Scenarioset 2
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
2.1 | Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje) | Aanvullende instructie (TA) | MBH_920_aanvullendeinstructie | MBH_920_aanvullendeinstructie_TA | MBH_920_aanvullendeinstructie_MVE |
2.2 | Maak screenshot(s) waaruit blijkt dat bij zowel de TA als MVE een 'toelichting' ingevoerd kan worden | Toelichting (TA), toelichting (MVE) | MBH_920_toelichting | MBH_920_toelichting_TA | MBH_920_toelichting_MVE |
2.3 | Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld. | Reden van voorschrijven (TA) | MBH_920_redenvanvoorschrijven | MBH_920_redenvanvoorschrijven_TA | MBH_920_redenvanvoorschrijven_MVE |
2.5 | Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (TA) en 'aanvullende wensen' (MVE) zichtbaar zijn | Aanvullende informatie (MA), aanvullende wensen (VV) | MBH_920_aanvullendeinformatiewensen | MBH_920_aanvullendeinformatiewensen_TA | MBH_920_aanvullendeinformatiewensen_MVE |
2.6 | Maak screenshot(s) waarop toedieningsweg keuze zichtbaar is | Toedieningsweg (TA) | MBH_920_Toedieningsweg | MBH_920_Toedieningsweg_TA | MBH_920_Toedieningsweg_MVE |
1.1.3 Scenarioset 3
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
3.1 | Stop-toedieningsafspraak, met reden staken LET OP: stop medicatieafspraak van scenario 2.1 |
MBH_920_aanvullendeinstructie | MBH_920_aanvullendeinstructie_TA_staken | ||
3.2 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijziging toedieningsafspraak, met reden wijziging (stop-TA + nieuwe TA) met MVE LET OP: wijziging toedieningsafspraak van scenario 2.2 |
MBH_920_toelichting | MBH_920_toelichting_TA_wijzigingmetMVE | MBH_920_toelichting_MVE_extra |
3.3 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijziging toediendingsafspraak, met reden wijziging (stop-TA + nieuwe ma) zonder MVE LET OP: wijziging toedieningsafspraak van scenario 2.3 |
MBH_920_redenvanvoorschrijven | MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE | |
3.4 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Onderbreken toedieningsafspraak LET OP: onderbreking toedieningsafspraak van scenario 2.4/2.5 |
MBH_920_aanvullendeinformatiewensen | MBH_920_aanvullendeinformatiewensen_TA_onderbreken | |
3.5 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt |
Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b |
MBH_920_start_duur2 | MBH_920_start_duur2_TA_techstaken MBH_920_start_duur2_TA_anderePRK |
MBH_920_start_duur2_MVE_anderePRK |
1.1.4 Scenarioset 6
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
6.1 | Variabele frequentie |
MBH_920_variabelefrequentie | MBH_920_variabelefrequentie_TA | MBH_920_variabelefrequentie_MVE | |
6.2 | Interval | MBH_920_interval | MBH_920_interval_TA | MBH_920_interval_MVE | |
6.3 | Variabele hoeveelheid (1) | MBH_920_variabelehoeveelheid | MBH_920_variabelehoeveelheid_TA | MBH_920_variabelehoeveelheid_MVE | |
6.4 | Zonder keerdosis | MBH_920_zonderkeerdosis | MBH_920_zonderkeerdosis_MVE | ||
6.5 | Bijzondere keerdosis | MBH_920_bijzonderekeerdosis | MBH_920_bijzonderekeerdosis_TA | MBH_920_bijzonderekeerdosis_MVE | |
6.6 | Variabele hoeveelheid (2) |
MBH_920_variabelehoeveelheid2 | MBH_920_variabelehoeveelheid2_TA | MBH_920_variabelehoeveelheid2_MVE | |
6.7a | Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden | Tijdstippen | MBH_920_tijdstippen_flexibel | MBH_920_tijdstippen_flexibel_TA | MBH_920_tijdstippen_flexibel_MVE |
6.7b | Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden | Tijdstippen | MBH_920_tijdstippen_niet_flexibel | MBH_920_tijdstippen_niet_flexibel_TA | MBH_920_tijdstippen_niet_flexibel_MVE |
6.8 | Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden | Weekdagen | MBH_920_weekdagen | MBH_920_weekdagen_TA | MBH_920_weekdagen_MVE |
6.9 | Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden | Dagdeel | MBH_920_dagdeel | MBH_920_dagdeel_TA | MBH_920_dagdeel_MVE |
6.10 | Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden | Cyclisch schema | MBH_920_cyclischschema | MBH_920_cyclischschema_TA | MBH_920_cyclischschema_MVE |
6.11 | Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden | Afbouw schema en doseerduur | MBH_920_afbouwschema | MBH_920_afbouwschema_TA | MBH_920_afbouwschema_MVE |
6.12 | Variabele hoeveelheid en maximum | MBH_920_variabelehoeveelheidenmaximum | MBH_920_variabelehoeveelheidenmaximum_TA | MBH_920_variabelehoeveelheidenmaximum_MVE | |
6.13 | Toedieningssnelheid | MBH_920_toedieningssnelheid | MBH_920_toedieningssnelheid_TA | MBH_920_toedieningssnelheid_MVE | |
6.14 | Toedieningsduur | MBH_920_toedieningsduur | MBH_920_toedieningsduur_TA | MBH_920_toedieningsduur_MVE | |
6.15 | Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid) | Zo nodig |
MBH_920_zonodig | MBH_920_zonodig_TA | MBH_920_zonodig_MVE |
1.1.5 Scenarioset 7
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
7.1 | Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden | Alle ingrediënten | MBH_920_magistraalalleingredienten | MBH_920_magistraalalleingredienten_TA | MBH_920_magistraalalleingredienten_MVE |
7.2 | Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden | Actief ingrediënt | MBH_920_magistraalactieveingredient | MBH_920_magistraalactieveingredient_TA | MBH_920_magistraalactieveingredient_MVE |
7.3 | Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt |
90 miljoen nummer | MBH_920_magistraal90miljoennr | MBH_920_magistraal90miljoennr_TA | MBH_920_magistraal90miljoennr_MVE |
1.1.6 Scenarioset 8
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
8.1 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Verstrekking onder andermans toedieningsafspraak | MBH_920_VVandermansMA-ZTP | MBH_920_MVEandermansTA_TA-ZTP | MBH_920_MVEandermansTA_MVE-ZTP |
8.2 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Stoppen andermans toedieningsafspraak | MBH_920_stakenandermansMA-ZTP | MBH_920_stakenandermansTA_TA2-ZTP | MBH_920_stakenandermansTA_andermansMVE-ZTP |
8.3 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt |
Onderbreken andermans toedieningsafspraak | MBH_920_onderbrekenandermansMA-ZTP | MBH_920_onderbrekenandermansTA_TA2-ZTP | MBH_920_onderbrekenandermansTA_andermansMVE-ZTP |
8.4 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt |
Wijzigen andermans medicatieafspraak |
MBH_920_wijzigenandermansMA-ZTP | MBH_920_wijzigenandermansTA_TA_techstaken-ZTP | MBH_920_wijzigenandermansTA_andermansMVE-ZTP |
1.1.7 Scenarioset 9
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
9.1a | Maak screenshot(s) waarin zichtbaar is dat een logistieke verbruiksperiode ingevoerd kan worden (ingangsdatum en duur/einddatum) |
Logistieke verbruiksperiode | MBH_920_logistiekeverbruiksperiode_start_eind-BSC | MBH_920_logistiekeverbruiksperiode_start_eind_TA-BSC | MBH_920_logistiekeverbruiksperiode_start_eind_MVE-BSC |
9.1b | Logistieke verbruiksperiode | MBH_920_logistiekeverbruiksperiode_eind-BSC | MBH_920_logistiekeverbruiksperiode_eind_TA-BSC | MBH_920_logistiekeverbruiksperiode_eind_MVE-BSC | |
9.1c | Logistieke verbruiksperiode | MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC | MBH_920_logistiekeverbruiksperiode_duur_dagen_TA-BSC | MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE-BSC | |
9.2 | Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden |
Herhalingen | MBH_920_herhalingen-BSC | MBH_920_herhalingen_TA-BSC | MBH_920_herhalingen_MVE-BSC |
9.3 | Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden |
Afleverlocatie | MBH_920_afleverlocatie-BSC | MBH_920_afleverlocatie_TA-BSC | MBH_920_afleverlocatie_MVE-BSC |
1.1.8 Scenarioset 10
Scenario | Screenshots? | Beschrijving | MBH id | TA id | MVE id |
10.1 | HPK geneesmiddel | MBH_920_HPKvoorschrijven | MBH_920_HPKvoorschrijven_TA | MBH_920_HPKvoorschrijven_MVE | |
10.2 | ZI-nr geneesmiddel |
MBH_920_ZINRvoorschrijven | MBH_920_ZINRvoorschrijven_TA | MBH_920_ZINRvoorschrijven_MVE |
1.2 Overzicht van scenario's voor ontvangend systeem
1.2.1 Scenarioset 1
Scenario | Beschrijving | MBH id | TA id | MVE id |
1.1 | Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum | MBH_920_start_eind | MBH_920_start_eind_TA | MBH_920_start_eind_MVE |
1.2a | Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken) | MBH_920_start_duur | MBH_920_start_duur_TA | MBH_920_start_duur_MVE |
1.2b | Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen) | MBH_920_start_duur2 | MBH_920_start_duur2_TA | MBH_920_start_duur2_MVE |
1.3 | Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie) | MBH_920_chronisch | MBH_920_chronisch_TA | MBH_920_chronisch_MVE |
1.4 | Extra MVE onder bestaande TA LET OP: MVE bij de bestaande TA uit scenario 1.3 |
MBH_920_chronisch | MBH_920_chronisch_TA | MBH_920_chronisch_MVE_extraMVEbestaandeTA |
1.5 | Afhandeling medicatievoorschrift met eenheid 'dosis/stuks' | MBH_920_dosis_stuks | MBH_920_dosis_stuks_TA | MBH_920_dosis_stuks_MVE |
1.2.2 Scenarioset 2
Scenario | Beschrijving | MBH id | TA id | MVE id |
2.1 | Aanvullende instructie (TA) | MBH_920_aanvullendeinstructie | MBH_920_aanvullendeinstructie_TA | MBH_920_aanvullendeinstructie_MVE |
2.2 | Toelichting (TA), toelichting (MVE) | MBH_920_toelichting | MBH_920_toelichting_TA | MBH_920_toelichting_MVE |
2.3 | Reden van voorschrijven (TA) | MBH_920_redenvanvoorschrijven | MBH_920_redenvanvoorschrijven_TA | MBH_920_redenvanvoorschrijven_MVE |
2.5 | Aanvullende informatie (MA), aanvullende wensen (VV) | MBH_920_aanvullendeinformatiewensen | MBH_920_aanvullendeinformatiewensen_TA | MBH_920_aanvullendeinformatiewensen_MVE |
2.6 | Toedieningsweg (TA) | MBH_920_Toedieningsweg | MBH_920_Toedieningsweg_TA | MBH_920_Toedieningsweg_MVE |
1.2.3 Scenarioset 3
Scenario | Beschrijving | MBH id | TA id | MVE id |
3.1 | Stop-toedieningsafspraak, met reden staken LET OP: stop medicatieafspraak van scenario 2.1 |
MBH_920_aanvullendeinstructie | MBH_920_aanvullendeinstructie_TA_staken | |
3.2 | Wijziging toedieningsafspraak, met reden wijziging (stop-TA + nieuwe TA) met MVE LET OP: wijziging toedieningsafspraak van scenario 2.2 |
MBH_920_toelichting | MBH_920_toelichting_TA_wijzigingmetMVE | MBH_920_toelichting_MVE_extra |
3.3 | Wijziging toediendingsafspraak, met reden wijziging (stop-TA + nieuwe ma) zonder MVE LET OP: wijziging toedieningsafspraak van scenario 2.3 |
MBH_920_redenvanvoorschrijven | MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE | |
3.4 | Onderbreken toedieningsafspraak LET OP: onderbreking toedieningsafspraak van scenario 2.4/2.5 |
MBH_920_aanvullendeinformatiewensen | MBH_920_aanvullendeinformatiewensen_TA_onderbreken | |
3.5 | Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b |
MBH_920_start_duur2 | MBH_920_start_duur2_TA_techstaken MBH_920_start_duur2_TA_anderePRK |
MBH_920_start_duur2_MVE_anderePRK |
1.2.4 Scenarioset 6
Scenario | Beschrijving | MBH id | TA id | MVE id |
6.1 | Variabele frequentie |
MBH_920_variabelefrequentie | MBH_920_variabelefrequentie_TA | MBH_920_variabelefrequentie_MVE |
6.2 | Interval | MBH_920_interval | MBH_920_interval_TA | MBH_920_interval_MVE |
6.3 | Variabele hoeveelheid (1) | MBH_920_variabelehoeveelheid | MBH_920_variabelehoeveelheid_TA | MBH_920_variabelehoeveelheid_MVE |
6.4 | Zonder keerdosis | MBH_920_zonderkeerdosis | MBH_920_zonderkeerdosis_MVE | |
6.5 | Bijzondere keerdosis | MBH_920_bijzonderekeerdosis | MBH_920_bijzonderekeerdosis_TA | MBH_920_bijzonderekeerdosis_MVE |
6.6 | Variabele hoeveelheid (2) |
MBH_920_variabelehoeveelheid2 | MBH_920_variabelehoeveelheid2_TA | MBH_920_variabelehoeveelheid2_MVE |
6.7a | Tijdstippen | MBH_920_tijdstippen_flexibel | MBH_920_tijdstippen_flexibel_TA | MBH_920_tijdstippen_flexibel_MVE |
6.7b | Tijdstippen | MBH_920_tijdstippen_niet_flexibel | MBH_920_tijdstippen_niet_flexibel_TA | MBH_920_tijdstippen_niet_flexibel_MVE |
6.8 | Weekdagen | MBH_920_weekdagen | MBH_920_weekdagen_TA | MBH_920_weekdagen_MVE |
6.9 | Dagdeel | MBH_920_dagdeel | MBH_920_dagdeel_TA | MBH_920_dagdeel_MVE |
6.10 | Cyclisch schema | MBH_920_cyclischschema | MBH_920_cyclischschema_TA | MBH_920_cyclischschema_MVE |
6.11 | Afbouw schema en doseerduur | MBH_920_afbouwschema | MBH_920_afbouwschema_TA | MBH_920_afbouwschema_MVE |
6.12 | Variabele hoeveelheid en maximum | MBH_920_variabelehoeveelheidenmaximum | MBH_920_variabelehoeveelheidenmaximum_TA | MBH_920_variabelehoeveelheidenmaximum_MVE |
6.13 | Toedieningssnelheid | MBH_920_toedieningssnelheid | MBH_920_toedieningssnelheid_TA | MBH_920_toedieningssnelheid_MVE |
6.14 | Toedieningsduur | MBH_920_toedieningsduur | MBH_920_toedieningsduur_TA | MBH_920_toedieningsduur_MVE |
6.15 | Zo nodig |
MBH_920_zonodig | MBH_920_zonodig_TA | MBH_920_zonodig_MVE |
1.2.5 Scenarioset 7
Scenario | Beschrijving | MBH id | TA id | MVE id |
7.1 | Alle ingrediënten | MBH_920_magistraalalleingredienten | MBH_920_magistraalalleingredienten_TA | MBH_920_magistraalalleingredienten_MVE |
7.2 | Actief ingrediënt | MBH_920_magistraalactieveingredient | MBH_920_magistraalactieveingredient_TA | MBH_920_magistraalactieveingredient_MVE |
7.3 | 90 miljoen nummer | MBH_920_magistraal90miljoennr | MBH_920_magistraal90miljoennr_TA | MBH_920_magistraal90miljoennr_MVE |
1.2.6 Scenarioset 8
Scenario | Beschrijving | MBH id | TA id | MVE id |
8.1 | Verstrekking onder andermans toedieningsafspraak | MBH_920_VVandermansMA-ZTP | MBH_920_MVEandermansTA_TA-ZTP | MBH_920_MVEandermansTA_MVE-ZTP |
8.2 | Stoppen andermans toedieningsafspraak | MBH_920_stakenandermansMA-ZTP | MBH_920_stakenandermansTA_TA2-ZTP | MBH_920_stakenandermansTA_andermansMVE-ZTP |
8.3 | Onderbreken andermans toedieningsafspraak | MBH_920_onderbrekenandermansMA-ZTP | MBH_920_onderbrekenandermansTA_TA2-ZTP | MBH_920_onderbrekenandermansTA_andermansMVE-ZTP |
8.4 | Wijzigen andermans medicatieafspraak |
MBH_920_wijzigenandermansMA-ZTP | MBH_920_wijzigenandermansTA_TA_techstaken-ZTP | MBH_920_wijzigenandermansTA_andermansMVE-ZTP |
1.2.7 Scenarioset 9
Scenario | Beschrijving | MBH id | TA id | MVE id |
9.1a | Logistieke verbruiksperiode | MBH_920_logistiekeverbruiksperiode_start_eind-BSC | MBH_920_logistiekeverbruiksperiode_start_eind_TA-BSC | MBH_920_logistiekeverbruiksperiode_start_eind_MVE-BSC |
9.1b | Logistieke verbruiksperiode | MBH_920_logistiekeverbruiksperiode_eind-BSC | MBH_920_logistiekeverbruiksperiode_eind_TA-BSC | MBH_920_logistiekeverbruiksperiode_eind_MVE-BSC |
9.1c | Logistieke verbruiksperiode | MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC | MBH_920_logistiekeverbruiksperiode_duur_dagen_TA-BSC | MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE-BSC |
9.2 | Herhalingen | MBH_920_herhalingen-BSC | MBH_920_herhalingen_TA-BSC | MBH_920_herhalingen_MVE-BSC |
9.3 | Afleverlocatie | MBH_920_afleverlocatie-BSC | MBH_920_afleverlocatie_TA-BSC | MBH_920_afleverlocatie_MVE-BSC |
1.2.8 Scenarioset 10
Scenario | Beschrijving | MBH id | TA id | MVE id |
10.1 | HPK geneesmiddel | MBH_920_HPKvoorschrijven | MBH_920_HPKvoorschrijven_TA | MBH_920_HPKvoorschrijven_MVE |
10.2 | ZI-nr geneesmiddel |
MBH_920_ZINRvoorschrijven | MBH_920_ZINRvoorschrijven_TA | MBH_920_ZINRvoorschrijven_MVE |
1.3 KWALIFICATIE Scenarioset 1 MA ingangsdatum einddatum
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.3.1 Scenario 1.1 - MBH_920_start_eind
Toedieningsafspraak MBH_920_start_eind_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 12:20 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 5 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 5 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_eind_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 12:20 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 5 stuks | ||
Geneesmiddel - primaire code | METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_start_eind_VV | ||
MBH identificatie | MBH_920_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.4 KWALIFICATIE Scenarioset 1 MA ingangsdatum en duur (weken)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.4.1 Scenario 1.2a - MBH_920_start_duur
Toedieningsafspraak MBH_920_start_duur_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 12:30 uur | ||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||
Ingangsdatum | T | ||
Gebruiksduur | 3 weken | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 3 weken, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_duur_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 12:30 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 21 stuks | ||
Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_start_duur_VV | ||
MBH identificatie | MBH_920_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.5 KWALIFICATIE Scenarioset 1 MA ingangsdatum duur (dagen)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.5.1 Scenario 1.2b - MBH_920_start_duur2
Toedieningsafspraak MBH_920_start_duur2_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 60 dagen om 12:30 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
Ingangsdatum | T - 60 dagen | ||
Gebruiksduur | 28 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_duur2_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 60 dagen om 12:30 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 28 stuks | ||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_start_duur2_VV | ||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.6 KWALIFICATIE Scenarioset 1 chronische medicatie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.6.1 Scenario 1.3 - MBH_920_chronisch
Toedieningsafspraak MBH_920_chronisch_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 30 dagen om 12:32 uur | ||
Gebruiksperiode | Vanaf T - 30 dagen | ||
Ingangsdatum | T - 30 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_chronisch_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 30 dagen om 12:32 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 21 stuks | ||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_chronisch_VV | ||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.7 KWALIFICATIE Scenarioset 1 extra VV onder bestaande MA
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.7.1 Scenario 1.4 - MBH_920_chronisch
Toedieningsafspraak MBH_920_chronisch_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 30 dagen om 12:32 uur | ||
Gebruiksperiode | Vanaf T - 30 dagen | ||
Ingangsdatum | T - 30 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_chronisch_MVE_extraMVEbestaandeTA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 10 dagen om 12:35 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 90 stuks | ||
Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_chronisch_VV_extraVVbestaandeMA | ||
MBH identificatie | MBH_920_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.8 KWALIFICATIE Scenarioset 1 MA met eeinheid 'dosis/stuks'
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Brugge | |||
Identificatienummer | 999900419 [BSN] | |||
Geboortedatum | 16 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.8.1 Scenario 1.5 - MBH_920_dosis_stuks
Toedieningsafspraak MBH_920_dosis_stuks_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 130 dagen om 12:35 uur | ||
Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | ||
Ingangsdatum | T - 130 dagen | ||
Einddatum | T - 101 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 1 dosis | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_dosis_stuks_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 130 dagen om 12:35 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 1 stuk | ||
Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_dosis_stuks_VV | ||
MBH identificatie | MBH_920_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.9 KWALIFICATIE Scenarioset 2 Aanvullende instructie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.9.1 Scenario 2.1 - MBH_920_aanvullendeinstructie
Toedieningsafspraak MBH_920_aanvullendeinstructie_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_aanvullendeinstructie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 4 maanden om 09:00 uur | ||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 8 maanden | ||
Ingangsdatum | T - 4 maanden | ||
Einddatum | T + 8 maanden | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_aanvullendeinstructie_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_aanvullendeinstructie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 4 maanden om 09:00 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 180 stuks | ||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_aanvullendeinstructie_VV | ||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.10 KWALIFICATIE Scenarioset 2 Toelichting
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.10.1 Scenario 2.2 - MBH_920_toelichting
Toedieningsafspraak MBH_920_toelichting_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 21 dagen om 09:02 uur | ||
Gebruiksperiode | Vanaf T - 21 dagen | ||
Ingangsdatum | T - 21 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | LASIX TABLET 40MG (code = '220515' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | In overleg met specialist | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toelichting_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 21 dagen om 09:02 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | LASIX TABLET 40MG (code = '220515' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
Relatie verstrekkingsverzoek | MBH_920_toelichting_VV | ||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.11 KWALIFICATIE Scenarioset 2 Reden van voorschrijven
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.11.1 Scenario 2.3 - MBH_920_redenvanvoorschrijven
Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_redenvanvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 13 dagen om 09:05 uur | ||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
Ingangsdatum | T - 13 dagen | ||
Einddatum | T + 14 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_redenvanvoorschrijven_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_redenvanvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 13 dagen om 09:05 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 20 stuks | ||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_redenvanvoorschrijven_VV | ||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.12 KWALIFICATIE Scenarioset 2 Aanvullende informatie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.12.1 Scenario 2.5 - MBH_920_aanvullendeinformatiewensen
Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_aanvullendeinformatiewensen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 5 dagen om 09:06 uur | ||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
Ingangsdatum | T - 4 dagen | ||
Einddatum | T + 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_aanvullendeinformatiewensen_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:06 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_aanvullendeinformatiewensen_VV | ||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.12.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.13 KWALIFICATIE Scenarioset 2 Toedieningsweg los
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.13.1 Scenario 2.6 - MBH_920_Toedieningsweg
Toedieningsafspraak MBH_920_Toedieningsweg_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 5 dagen om 09:15 uur | ||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | ||
Ingangsdatum | T - 5 dagen | ||
Einddatum | T + 2 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair | ||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
Doseerinstructie | 2 maal per dag 1 druppel | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_Toedieningsweg_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_Toedieningsweg_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:15 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 1 stuk | ||
Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_Toedieningsweg_VV | ||
MBH identificatie | MBH_920_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.13.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.14 KWALIFICATIE Scenarioset 3 Stop-MA aanvullende instructie met reden van staken
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.14.1 Scenario 3.1 - MBH_920_aanvullendeinstructie
Toedieningsafspraak MBH_920_aanvullendeinstructie_TA_staken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_aanvullendeinstructie_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 10 dagen om 19:00 uur | ||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | ||
Ingangsdatum | T - 4 maanden | ||
Einddatum | T - 10 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | ||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_aanvullendeinstructie_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_Jansen_en_Co | |||
Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek Jansen en Co |
1.15 KWALIFICATIE Scenarioset 3 Wijzigen MA toelichting met reden wijziging
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.15.1 Scenario 3.2 - MBH_920_toelichting
Toedieningsafspraak MBH_920_toelichting_TA_wijzigingmetMVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toelichting_TA_wijzigingmetMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 2 dagen om 09:02 uur | ||
Gebruiksperiode | Vanaf T - 2 dagen | ||
Ingangsdatum | T - 2 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_toelichting_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toelichting_MVE_extra | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toelichting_MVE_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 2 dagen om 09:02 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 60 stuks | ||
Geneesmiddel - primaire code | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_toelichting_VV_extra | ||
MBH identificatie | MBH_920_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.15.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.16 KWALIFICATIE Scenarioset 3 Wijzigen MA reden van voorschrijven met reden van wijzigen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.16.1 Scenario 3.3 - MBH_920_redenvanvoorschrijven
Toedieningsafspraak MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_redenvanvoorschrijven_TA_wijzigingzonderMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 1 dag om 09:10 uur | ||
Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 14 dagen | ||
Ingangsdatum | T - 1 dag | ||
Einddatum | T + 14 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | ||
Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 4 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.16.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_Jansen_en_Co | |||
Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek Jansen en Co |
1.17 KWALIFICATIE Scenarioset 3 onderbreken MA toedieningsweg
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.17.1 Scenario 3.4 - MBH_920_aanvullendeinformatiewensen
Toedieningsafspraak MBH_920_aanvullendeinformatiewensen_TA_onderbreken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_aanvullendeinformatiewensen_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 1 dag om 19:12 uur | ||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T - 1 dag | ||
Ingangsdatum | T - 4 dagen | ||
Einddatum | T - 1 dag | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_Jansen_en_Co | ||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_aanvullendeinformatiewensen_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.17.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_Jansen_en_Co | |||
Zorgaanbieder identificatienummer | 99901111 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek Jansen en Co |
1.18 KWALIFICATIE Scenarioset 3 wijziging TA
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Coenen | |||
Identificatienummer | 999900420 [BSN] | |||
Geboortedatum | 17 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.18.1 Scenario 3.5 - MBH_920_start_duur2
Toedieningsafspraak MBH_920_start_duur2_TA_techstaken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur2_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 50 dagen om 12:30 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 51 dagen | ||
Ingangsdatum | T - 60 dagen | ||
Einddatum | T - 51 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, tot en met T - 51 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_920_start_duur2_TA_anderePRK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur2_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 50 dagen om 12:35 uur | ||
Gebruiksperiode | Vanaf T - 50 dagen, gedurende 18 dagen | ||
Ingangsdatum | T - 50 dagen | ||
Gebruiksduur | 18 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Reden afspraak | Pantozol niet leverbaar | ||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_start_duur2_MVE_anderePRK | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_start_duur2_MVE_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 50 dagen om 12:36 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 28 stuks | ||
Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_start_duur2_VV | ||
MBH identificatie | MBH_920_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.18.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.19 KWALIFICATIE Scenarioset 6 Variabele frequentie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.19.1 Scenario 6.1 - MBH_920_variabelefrequentie
Toedieningsafspraak MBH_920_variabelefrequentie_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:00 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 16 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 16 dagen, maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelefrequentie_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelefrequentie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:00 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 90 stuks | ||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_variabelefrequentie_VV | ||
MBH identificatie | MBH_920_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.19.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.20 KWALIFICATIE Scenarioset 6 Interval
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.20.1 Scenario 6.2 - MBH_920_interval
Toedieningsafspraak MBH_920_interval_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:04 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, exact iedere 8 uur 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | exact iedere 8 uur 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_interval_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_interval_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:04 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 90 stuks | ||
Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_interval_VV | ||
MBH identificatie | MBH_920_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.20.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.21 KWALIFICATIE Scenarioset 6 Variabele hoeveelheid
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.21.1 Scenario 6.3 - MBH_920_variabelehoeveelheid
Toedieningsafspraak MBH_920_variabelehoeveelheid_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:10 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | PARACETAMOLUM TABLET 500MG (code = '244716' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelehoeveelheid_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelehoeveelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:10 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 100 stuks | ||
Geneesmiddel - primaire code | PARACETAMOLUM TABLET 500MG (code = '244716' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_variabelehoeveelheid_VV | ||
MBH identificatie | MBH_920_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.21.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.22 KWALIFICATIE Scenarioset 6 Zonder keerdosis
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.22.1 Scenario 6.4 - MBH_920_zonderkeerdosis
Medicatieverstrekking MBH_920_zonderkeerdosis_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_zonderkeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:12 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 1 stuk | ||
Geneesmiddel - primaire code | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_zonderkeerdosis_VV | ||
MBH identificatie | MBH_920_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.22.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.23 KWALIFICATIE Scenarioset 6 Bijzondere keerdosis
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.23.1 Scenario 6.5 - MBH_920_bijzonderekeerdosis
Toedieningsafspraak MBH_920_bijzonderekeerdosis_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:15 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 0.5 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_bijzonderekeerdosis_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_bijzonderekeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:15 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_bijzonderekeerdosis_VV | ||
MBH identificatie | MBH_920_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.23.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.24 KWALIFICATIE Scenarioset 6 Variabele hoeveelheid 2
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.24.1 Scenario 6.6 - MBH_920_variabelehoeveelheid2
Toedieningsafspraak MBH_920_variabelehoeveelheid2_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:18 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | ||
Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 2 maal per dag ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelehoeveelheid2_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelehoeveelheid2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:18 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 450 ml | ||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_variabelehoeveelheid2_VV | ||
MBH identificatie | MBH_920_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.24.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.25 KWALIFICATIE Scenarioset 6 Tijdstippen flexibel
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.25.1 Scenario 6.7a - MBH_920_tijdstippen_flexibel
Toedieningsafspraak MBH_920_tijdstippen_flexibel_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:24 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 14 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_tijdstippen_flexibel_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_tijdstippen_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:24 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 42 stuks | ||
Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_tijdstippen_flexibel_VV | ||
MBH identificatie | MBH_920_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.25.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.26 KWALIFICATIE Scenarioset 6 Tijdstippen niet flexibel
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.26.1 Scenario 6.7b - MBH_920_tijdstippen_niet_flexibel
Toedieningsafspraak MBH_920_tijdstippen_niet_flexibel_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 10:15 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden., oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk , let op! Tijden exact aanhouden. | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_tijdstippen_niet_flexibel_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_tijdstippen_niet_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 10:17 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 21 stuks | ||
Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_tijdstippen_niet_flexibel_VV | ||
MBH identificatie | MBH_920_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.26.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.27 KWALIFICATIE Scenarioset 6 Weekdagen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.27.1 Scenario 6.8 - MBH_920_weekdagen
Toedieningsafspraak MBH_920_weekdagen_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:25 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 70 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | ||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | op maandag, woensdag en vrijdag | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_weekdagen_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_weekdagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:25 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_weekdagen_VV | ||
MBH identificatie | MBH_920_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.27.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.28 KWALIFICATIE Scenarioset 6 Dagdeel
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.28.1 Scenario 6.9 - MBH_920_dagdeel
Toedieningsafspraak MBH_920_dagdeel_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:27 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, 1 stuk 's avonds, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 stuk 's avonds | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_dagdeel_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_dagdeel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:27 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 60 stuks | ||
Geneesmiddel - primaire code | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_dagdeel_VV | ||
MBH identificatie | MBH_920_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.28.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.29 KWALIFICATIE Scenarioset 6 Cyclisch schema
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.29.1 Scenario 6.10 - MBH_920_cyclischschema
Toedieningsafspraak MBH_920_cyclischschema_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:33 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_cyclischschema_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_cyclischschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:33 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 126 stuks | ||
Geneesmiddel - primaire code | MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_cyclischschema_VV | ||
MBH identificatie | MBH_920_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.29.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.30 KWALIFICATIE Scenarioset 6 Afbouwschema
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.30.1 Scenario 6.11 - MBH_920_afbouwschema
Toedieningsafspraak MBH_920_afbouwschema_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:40 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 41 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_afbouwschema_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_afbouwschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:40 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 90 gram | ||
Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_afbouwschema_VV | ||
MBH identificatie | MBH_920_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.30.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.31 KWALIFICATIE Scenarioset 6 Variabele hoeveelheid en maximum
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.31.1 Scenario 6.12 - MBH_920_variabelehoeveelheidenmaximum
Toedieningsafspraak MBH_920_variabelehoeveelheidenmaximum_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:45 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 21 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 21 dagen, Bij hoest stuks , maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Bij hoest stuks , maximaal 6 stuks per dag | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_variabelehoeveelheidenmaximum_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_variabelehoeveelheidenmaximum_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:45 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 120 stuks | ||
Geneesmiddel - primaire code | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_variabelehoeveelheidenmaximum_VV | ||
MBH identificatie | MBH_920_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.31.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.32 KWALIFICATIE Scenarioset 6 Toedieningssnelheid
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.32.1 Scenario 6.13 - MBH_920_toedieningssnelheid
Toedieningsafspraak MBH_920_toedieningssnelheid_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:47 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 8 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: ml per uur, parenteraal | ||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | toedieningssnelheid: ml per uur | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toedieningssnelheid_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toedieningssnelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:47 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 100 ml | ||
Geneesmiddel - primaire code | MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_toedieningssnelheid_VV | ||
MBH identificatie | MBH_920_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.32.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.33 KWALIFICATIE Scenarioset 6 Toedieningsduur
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.33.1 Scenario 6.14 - MBH_920_toedieningsduur
Toedieningsafspraak MBH_920_toedieningsduur_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:49 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, 1 maal per dag 1 stuk, transdermaal | ||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_toedieningsduur_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_toedieningsduur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:49 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_toedieningsduur_VV | ||
MBH identificatie | MBH_920_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.33.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.34 MP KWALIFICATIE Scenarioset 6 Zo nodig
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hemsbergen | |||
Identificatienummer | 999900602 [BSN] | |||
Geboortedatum | 2 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.34.1 Scenario 6.15 - MBH_920_zonodig
Toedieningsafspraak MBH_920_zonodig_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 09:57 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 27 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_zonodig_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_zonodig_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 09:57 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_de_Gulle_Gaper | ||
Verstrekte hoeveelheid | 14 stuks | ||
Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_zonodig_VV | ||
MBH identificatie | MBH_920_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.34.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_de_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek de Gulle Gaper |
1.35 KWALIFICATIE Scenarioset 7 alle ingrediënten
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hess | |||
Identificatienummer | 999900614 [BSN] | |||
Geboortedatum | 3 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.35.1 Scenario 7.1 - MBH_920_magistraalalleingredienten
Toedieningsafspraak MBH_920_magistraalalleingredienten_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 13:00 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 31 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
Ingredient | ||||
Ingredient code | UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Ingredient | ||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | Zo nodig | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_magistraalalleingredienten_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 13:00 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 ml | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
Ingredient | ||||
Ingredient code | UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Ingredient | ||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Relatie verstrekkingsverzoek | MBH_920_magistraalalleingredienten_VV | |||
MBH identificatie | MBH_920_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.35.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.36 KWALIFICATIE Scenarioset 7 Actief ingrediënt
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hess | |||
Identificatienummer | 999900614 [BSN] | |||
Geboortedatum | 3 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.36.1 Scenario 7.2 - MBH_920_magistraalactieveingredient
Toedieningsafspraak MBH_920_magistraalactieveingredient_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 13:05 uur | |||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | |||
Ingangsdatum | T + 1 dag | |||
Einddatum | T + 70 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | |||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
Ingredient | ||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_magistraalactieveingredient_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 13:05 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 gram | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | |||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
Ingredient | ||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Relatie verstrekkingsverzoek | MBH_920_magistraalactieveingredient_VV | |||
MBH identificatie | MBH_920_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.36.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.37 KWALIFICATIE Scenarioset 7 90 miljoennummer
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Hess | |||
Identificatienummer | 999900614 [BSN] | |||
Geboortedatum | 3 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.37.1 Scenario 7.3 - MBH_920_magistraal90miljoennr
Toedieningsafspraak MBH_920_magistraal90miljoennr_TA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
Toedieningsafspraak datum tijd | T om 13:08 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 30 dagen | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Geneesmiddel - Product specificatie | ||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | |||
Product naam | Ureum 10% in eucerine cum aqua 100gr | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
Ingredient | ||||
Ingredient code | UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag | |||
Relatie medicatieafspraak | ||||
Identificatie | MBH_920_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_magistraal90miljoennr_MVE | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_920_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
Medicatieverstrekkings datum tijd | T om 13:08 uur | |||
Verstrekker | ||||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | |||
Verstrekte hoeveelheid | 100 gram | |||
Geneesmiddel - Product specificatie | ||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | |||
Product naam | Ureum 10% in eucerine cum aqua 100gr | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
Ingredient | ||||
Ingredient code | UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Relatie verstrekkingsverzoek | MBH_920_magistraal90miljoennr_VV | |||
MBH identificatie | MBH_920_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.37.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.38 KWALIFICATIE Scenarioset 8 VV onder andermans MA
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | L. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Meijs | |||
Identificatienummer | 999900808 [BSN] | |||
Geboortedatum | 26 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.38.1 Scenario 8.1 - MBH_920_VVandermansMA-ZTP
Toedieningsafspraak MBH_920_MVEandermansTA_TA-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_MVEandermansTA_TA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 14 dagen om 10:00 uur | ||
Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 6 dagen | ||
Ingangsdatum | T - 14 dagen | ||
Einddatum | T + 6 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_VVandermansMA_MA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_VVandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_MVEandermansTA_MVE-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_MVEandermansTA_MVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 10:00 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 6 stuks | ||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_VVandermansMA_VV-ZTP | ||
MBH identificatie | MBH_920_VVandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.38.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.39 KWALIFICATIE Scenarioset 8 Staken andermans MA
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | L. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Meijs | |||
Identificatienummer | 999900808 [BSN] | |||
Geboortedatum | 26 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.39.1 Scenario 8.2 - MBH_920_stakenandermansMA-ZTP
Toedieningsafspraak MBH_920_stakenandermansTA_TA2-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_stakenandermansTA_TA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 10:05 uur | ||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T | ||
Ingangsdatum | T - 5 dagen | ||
Einddatum | T | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | ZESTRIL TABLET 10MG (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_stakenandermansMA_MA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_stakenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_stakenandermansTA_andermansMVE-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_stakenandermansTA_andermansMVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 5 dagen om 09:45 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 21 stuks | ||
Geneesmiddel - primaire code | ZESTRIL TABLET 10MG (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_stakenandermansMA_andermansVV-ZTP | ||
MBH identificatie | MBH_920_stakenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.39.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.40 KWALIFICATIE Scenarioset 8 Onderbreken andermans MA
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | L. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Meijs | |||
Identificatienummer | 999900808 [BSN] | |||
Geboortedatum | 26 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.40.1 Scenario 8.3 - MBH_920_onderbrekenandermansMA-ZTP
Toedieningsafspraak MBH_920_onderbrekenandermansTA_TA2-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_onderbrekenandermansTA_TA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 10:07 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T | ||
Ingangsdatum | T - 60 dagen | ||
Einddatum | T | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_onderbrekenandermansMA_MA2-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_onderbrekenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_onderbrekenandermansTA_andermansMVE-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_onderbrekenandermansTA_andermansMVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 60 dagen om 10:00 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 90 stuks | ||
Geneesmiddel - primaire code | APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK') | ||
Geneesmiddel - generiekere code | APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_onderbrekenandermansMA_andermansVV-ZTP | ||
MBH identificatie | MBH_920_onderbrekenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.40.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.41 KWALIFICATIE Scenarioset 8 Wijzigen andermans MA
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | L. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Meijs | |||
Identificatienummer | 999900808 [BSN] | |||
Geboortedatum | 26 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.41.1 Scenario 8.4 - MBH_920_wijzigenandermansMA-ZTP
Toedieningsafspraak MBH_920_wijzigenandermansTA_TA_techstaken-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_wijzigenandermansTA_TA_techstaken-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 10:10 uur | ||
Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 1 dag | ||
Ingangsdatum | T - 7 dagen | ||
Einddatum | T - 1 dag | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_wijzigenandermansMA_MA_techstaken-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_wijzigenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_wijzigenandermansTA_andermansMVE-ZTP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_wijzigenandermansTA_andermansMVE-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 7 dagen om 08:50 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 42 stuks | ||
Geneesmiddel - primaire code | FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_wijzigenandermansMA_andermansVV-ZTP | ||
MBH identificatie | MBH_920_wijzigenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.41.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.42 KWALIFICATIE Scenarioset 9 Verbruiksperiode (start/eind)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Nederveen | |||
Identificatienummer | 999900833 [BSN] | |||
Geboortedatum | 28 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.42.1 Scenario 9.1a - MBH_920_logistiekeverbruiksperiode_start_eind-BSC
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_start_eind_TA-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 12:00 uur | ||
Gebruiksperiode | Vanaf T + 10 dagen, tot en met T + 12 maanden | ||
Ingangsdatum | T + 10 dagen | ||
Einddatum | T + 12 maanden | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_start_eind_MVE-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_logistiekeverbruiksperiode_start_eind_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 12:00 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 100 stuks | ||
Geneesmiddel - primaire code | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_logistiekeverbruiksperiode_start_eind_VV-BSC | ||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.42.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.43 KWALIFICATIE Scenarioset 9 Verbruiksperiode einddatum
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Nederveen | |||
Identificatienummer | 999900833 [BSN] | |||
Geboortedatum | 28 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.43.1 Scenario 9.1b - MBH_920_logistiekeverbruiksperiode_eind-BSC
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_eind_TA-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 9 dagen om 12:01 uur | ||
Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 200 dagen | ||
Ingangsdatum | T - 9 dagen | ||
Einddatum | T + 200 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_eind_MVE-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_logistiekeverbruiksperiode_eind_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 9 dagen om 12:01 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 100 stuks | ||
Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_logistiekeverbruiksperiode_eind_VV-BSC | ||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.43.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.44 KWALIFICATIE Scenarioset 9 verbruiksperiode duur (dagen)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Nederveen | |||
Identificatienummer | 999900833 [BSN] | |||
Geboortedatum | 28 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.44.1 Scenario 9.1c - MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC
Toedieningsafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_TA-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 12:02 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 150 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 12:02 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 100 stuks | ||
Verbruiksduur | 50 dagen | ||
Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_logistiekeverbruiksperiode_duur_dagen_VV-BSC | ||
MBH identificatie | MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.44.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.45 KWALIFICATIE Scenarioset 9 Herhalingen
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Nederveen | |||
Identificatienummer | 999900833 [BSN] | |||
Geboortedatum | 28 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.45.1 Scenario 9.2 - MBH_920_herhalingen-BSC
Toedieningsafspraak MBH_920_herhalingen_TA-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_herhalingen_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 50 dagen om 12:05 uur | ||
Gebruiksperiode | Vanaf T - 50 dagen | ||
Ingangsdatum | T - 50 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_herhalingen_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_herhalingen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_herhalingen_MVE-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_herhalingen_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 50 dagen om 12:05 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_herhalingen_VV-BSC | ||
MBH identificatie | MBH_920_herhalingen-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.45.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.46 KWALIFICATIE Scenarioset 9 Afleverlocatie
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Nederveen | |||
Identificatienummer | 999900833 [BSN] | |||
Geboortedatum | 28 okt 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.46.1 Scenario 9.3 - MBH_920_afleverlocatie-BSC
Toedieningsafspraak MBH_920_afleverlocatie_TA-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_afleverlocatie_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 12:07 uur | ||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 10 dagen | ||
Ingangsdatum | T + 1 dag | ||
Einddatum | T + 10 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_afleverlocatie_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_afleverlocatie-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_afleverlocatie_MVE-BSC | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_afleverlocatie_MVE-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 12:07 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | ||
Relatie verstrekkingsverzoek | MBH_920_afleverlocatie_VV-BSC | ||
MBH identificatie | MBH_920_afleverlocatie-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.46.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.47 KWALIFICATIE Scenarioset 10 HPK geneesmiddel
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Niesing | |||
Identificatienummer | 999900845 [BSN] | |||
Geboortedatum | 29 okt 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.47.1 Scenario 10.1 - MBH_920_HPKvoorschrijven
Toedieningsafspraak MBH_920_HPKvoorschrijven_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T - 170 dagen om 14:00 uur | ||
Gebruiksperiode | Vanaf T - 170 dagen, tot en met T - 21 dagen | ||
Ingangsdatum | T - 170 dagen | ||
Einddatum | T - 21 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_HPKvoorschrijven_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T - 170 dagen om 14:00 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 150 stuks | ||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_HPKvoorschrijven_VV | ||
MBH identificatie | MBH_920_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.47.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |
1.48 KWALIFICATIE Scenarioset 10 ZI-nummer geneesmiddel
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Niesing | |||
Identificatienummer | 999900845 [BSN] | |||
Geboortedatum | 29 okt 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.48.1 Scenario 10.2 - MBH_920_ZINRvoorschrijven
Toedieningsafspraak MBH_920_ZINRvoorschrijven_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Toedieningsafspraak datum tijd | T om 14:05 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 150 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Geneesmiddel - primaire code | INDAPAMIDE SANDOZ TABLET 2,5MG (code = '14896087' in codeSystem 'G-Standaard ZI-nr') | ||
Geneesmiddel - generiekere code | INDAPAMIDE SANDOZ TABLET 2,5MG (code = '685410' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_920_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieverstrekking MBH_920_ZINRvoorschrijven_MVE | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_920_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Medicatieverstrekkings datum tijd | T om 14:05 uur | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper | ||
Verstrekte hoeveelheid | 150 stuks | ||
Geneesmiddel - primaire code | INDAPAMIDE SANDOZ TABLET 2,5MG (code = '14896087' in codeSystem 'G-Standaard ZI-nr') | ||
Geneesmiddel - generiekere code | INDAPAMIDE SANDOZ TABLET 2,5MG (code = '685410' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
Relatie verstrekkingsverzoek | MBH_920_ZINRvoorschrijven_VV | ||
MBH identificatie | MBH_920_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.48.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder Apotheek_De_Gulle_Gaper | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper |